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1  
English 
Streptococcus pneumoniae (Pneumococcus) is one of the leading causes of childhood meningitis, 
pneumonia and sepsis. Despite the availability of childhood vaccination programs and antimicrobial 
agents, childhood pneumococcal meningitis is still a devastating illness with mortality rates among 
the highest of any cause of bacterial meningitis. Especially in low-income countries, where medical 
care is less accessible, mortality rates up to 50 % have been reported. In surviving patients, 
neurological sequelae, including hearing loss, focal neurological deficits and cognitive impairment, is 
reported in 30 to 50 %. Growing resistance of pneumococci towards conventional antibiotics 
emphasize the need for effective therapies and development of effective vaccines against 
Streptococcus pneumoniae.  
One major virulence factor of Streptococcus pneumoniae is the protein toxin Pneumolysin (PLY). PLY 
belongs to a family of structurally related toxins, the so-called cholesterol-dependent cytolysins 
(CDCs). Pneumolysin is produced by almost all clinical isolates of the bacterium. It is expressed during 
the late log phase of bacterial growth and gets released mainly through spontaneous autolysis of the 
bacterial cell. After binding to cholesterol in the host cell membranes, oligomerization of up to 50 
toxin monomers and rearrangement of the protein structure, PLY forms large pores, leading to cell 
lysis in higher toxin concentrations. At sub-lytic concentrations, however, PLY mediates several other 
effects, such as activation of the classic complement pathway and the induction of apoptosis. 
First experiments with pneumococcal strains, deficient in pneumolysin, showed a reduced virulence 
of the organism, which emphasizes the contribution of this toxin to the course of bacterial meningitis 
and the urgent need for the understanding of the multiple mechanisms leading to invasive 
pneumococcal disease. 
The aim of this thesis was to shed light on the contribution of pneumolysin to the course of the 
disease as well as to the mental illness patients are suffering from after recovery from pneumococcal 
meningitis.  
Therefore, we firstly investigated the effects of sub-lytic pneumolysin concentrations onto primary 
mouse neurons, transfected with a GFP construct and imaged with the help of laser scanning 
confocal microscopy. We discovered two major morphological changes in the dendrites of primary 
mouse neurons: The formation of focal swellings along the dendrites (so-called varicosities) and the 
reduction of dendritic spines.  
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To study these effects in a more complex system, closer to the in vivo situation, we established a 
reproducible method for acute brain slice culturing. With the help of this culturing method, we were 
able to discover the same morphological changes in dendrites upon challenge with sub-lytic 
concentrations of pneumolysin. We were able to reverse the seen alterations in dendritic structure 
with the help of two antagonists of the NMDA receptor, connecting the toxin´s mode of action to a 
non-physiological stimulation of this subtype of glutamate receptors.  
The loss of dendritic spines (representing the postsynapse) in our brain slice model could be verified 
with the help of brain slices from adult mice, suffering from pneumococcal meningitis. By 
immunohistochemical staining with an antibody against synapsin I, serving as a presynaptic marker, 
we were able to identify a reduction of synapsin I in the cortex of mice, infected with a 
pneumococcal strain which is capable of producing pneumolysin. The reduction of synapsin I was 
higher in these brain slices compared to mice infected with a pneumococcal strain which is not 
capable of producing pneumolysin, illustrating a clear role for the toxin in the reduction of dendritic 
spines.  
The fact that the seen effects weren´t abolished under calcium free conditions clarifies that not only 
the influx of calcium through the pneumolysin-pore is responsible for the alterations. These findings 
were further supported by calcium imaging experiments, where an inhibitor of the NMDA receptor 
was capable of delaying the time point, when the maximum of calcium influx upon PLY challenge was 
reached. 
Additionally, we were able to observe the dendritic beadings with the help of immunohistochemistry 
with an antibody against MAP2, a neuron-specific cytoskeletal protein. These observations also 
connect pneumolysin´s mode of action to excitotoxicity, as several studies mention the aggregation 
of MAP2 in dendritic beadings in response to excitotoxic stimuli.  
 
All in all, this is the first study connecting pneumolysin to excitotoxic events, which might be a novel 
chance to tie in other options of treatment for patients suffering from pneumococcal meningitis. 
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Deutsch 
Streptococcus pneumoniae ist einer der Hauptauslöser für bakterielle Meningitis, Lungenentzündung 
und Sepsis. Ungeachtet der Tatsache, dass es heutzutage viele Impfprogramme zur Prävention, sowie 
Antibiotika zur Behandlung gibt, ist die bakterielle Meningitis im Kindesalter, ausgelöst durch 
S. pneumoniae, immer noch eine ernstzunehmende Krankheit mit Sterberaten von bis zu 50 %. Dies 
gilt im Besonderen für Schwellen- und Entwicklungsländer, wo der Zugang zu medizinischer 
Versorgung sehr schwer bis unmöglich ist. Bei 30 bis 50 % der Patienten, die die Krankheit 
überstehen, bleiben teilweise schwere neurologische Störungen, wie z.B. Taubheit und Störungen 
kognitiver Fähigkeiten, zurück. Die steigende Resistenz des Erregers gegenüber herkömmlichen 
Antibiotika macht zudem die Dringlichkeit zur Entwicklung effektiver Therapieansätze und Impfstoffe 
deutlich.  
Ein Hauptpathogenitätsfaktor von Streptococcus pneumoniae ist das Proteintoxin Pneumolysin (PLY). 
PLY gehört zu einer Familie strukturell verwandter Toxine; die sogenannten cholesterinabhängigen 
Cytolysine (CDCs). Pneumolysin wird von praktisch allen klinisch isolierten Pneumokokkenstämmen 
produziert. Die Expression findet in der späten log-Phase des Bakterienwachstums statt. Das Toxin 
wird hauptsächlich nach spontaner Autolyse des Bakteriums freigesetzt. Nach Bindung des Proteins 
an das Cholesterin in den Zellmembranen des Wirtsorganismus, Oligomerisierung von bis zu 
50 Toxinmonomeren und Umordnung der Proteinstruktur, bildet das Toxin Poren in der 
Zellmembran, die in höheren Konzentrationen von PLY zur Zelllyse führen. In niedrigeren 
Konzentrationen löst das Toxin jedoch verschiedene andere Prozesse, darunter Apoptose und 
Aktivierung des Komplementsystems, aus. 
Erste Experimente, die mit einem mutierten Pneumokokkenstamm (unfähig, Pneumolysin zu 
exprimieren) durchgeführt wurden, konnten eine reduzierte Virulez des Erregers zeigen, was die 
Beteiligung des Toxins am Verlauf der Krankheit verdeutlicht und klar macht, wie wichtig es ist, die 
Prozesse zu verstehen, die insbesondere zu einem schweren Verlauf der Krankheit führen. 
Ziel vorliegender Arbeit war, die Beteiligung von Pneumolysin sowohl am Verlauf der bakteriellen 
Meningitis, hervorgerufen durch Pneumolysin, zu erforschen, als auch dessen Beteiligung an der 
Entstehung von neurologischen Störungen, wie sie auch nach Rehabilitation von einer Meningitis 
noch bestehen können. 
Dafür wurden zuerst die Effekte von sublytischen Konzentrationen des Toxins auf primäre 
Mausneuronen (transfiziert mit GFP und mit Hilfe eines Konfokalmikroskopes aufgenommen) erfasst. 
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Dabei zeigten sich hauptsächlich zwei morphologische Veränderungen in den Dendriten der 
mikroskopierten Neurone: Die Entstehung von fokalen Schwellungen der Dendriten (sogenannte 
„varicosities“) sowie eine Verminderung der Anzahl von dendritischen Dornfortsätzen (sogenannte 
„dendritic spines“).  
Um diese Effekte in einem komplexeren System näher untersuchen zu können, entwickelten wir eine 
reproduzierbare Methode um akute Gehirnschnitte über längere Zeit kultivieren zu können. Mithilfe 
dieser Methode konnten wir die Veränderungen, die wir schon in der Primärkultur beobachteten, 
auch in diesem komplexen System (das näher an der in vivo Situation ist) nachweisen. Die 
Entwicklung der fokalen Schwellungen der Dendriten konnten mithilfe zweier Antagonisten des 
NMDA Rezeptors rückgängig gemacht werden, wodurch erstmals eine Verbindung der Effekte mit 
einer Aktivierung von Glutamatrezeptoren aufgezeigt wurde. 
Die Verminderung der Anzahl dendritischer Dornfortsätze im Gehirnschnittmodell wurde 
untermauert von den Ergebnissen, die wir durch Gehirnschnitte von Mäusen, die tatsächlich an 
pneumokokkaler Meningitis erkrankt waren, erlangen konnten. Durch immunohistologische 
Färbungen mit einem Antikörper gegen Synapsin I (ein präsynaptisches Protein) konnten wir eine 
Reduktion dieses Proteins im Cortex erkrankter Mäuse nachweisen. Die Reduktion des Synapsin I 
Signals war höher bei den Mäusen, die mit Pneumokokken infiziert waren, die zur PLY Produktion 
befähigt waren, im Vergleich zu den Hirnschnitten der Mäuse, die ebenfalls an einer Meningitis, 
jedoch hervorgerufen durch eine Mutante von Streptococcus pneumoniae (unfähig, Pneumolysin zu 
exprimieren) litten. 
Die Tatsache, dass die morphologischen Veränderungen der Dendriten ebenfalls in calciumfreiem 
Puffer beobachtet werden konnten, macht deutlich, dass nicht nur der Calciuminflux durch die 
Pneumolysinpore verantwortlich ist für dessen Neurotoxizität. Diese These wird untermauert durch 
die Ergebnisse, die wir mithilfe der Calciummikroskopie erhielten: Die Applikation eines Antagonisten 
des NMDA Rezeptors konnte den Zeitpunkt des maximalen Calciuminfluxes in die Zelle nach 
Behandlung mit Pneumolysin hinauszögern. 
Zudem konnten wir die Schwellungen in den Dendriten auch durch einen Antikörper gegen MAP2 
(ein neuronenspezifisches Protein des Zytoskeletts) darstellen, was ebenfalls eine Verbindung von 
Pneumolysin zu „excitotoxicity“ (Toxizität aufgrund einer Übererregung von Glutamatrezeptoren) 
darstellt, da verschiedene Studien die Aggregation von MAP2 in fokalen dendritischen Schwellungen 
als Reaktion auf die Einwirkung von „excitotoxischen“ Stimuli nachweisen konnten.      
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Zusammenfassend lässt sich sagen, dass dies die erste Studie ist, die Pneumolysin in Zusammenhang 
mit einer Überaktivierung von Glutamatrezeptoren bringt, was eine komplett neue Sichtweise 
darstellt und eventuell neue Möglichkeiten der Therapie für Patienten, die an dieser Form der 
bakteriellen Hirnhautentzündung leiden, eröffnet.  
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2  
2.1 Streptococcus pneumoniae 
 
 
Figure 1: Streptococcus pneumoniae (SEM) 
Scanning electron micrograph (SEM) of the pathogen. Gram-positive Pneumococci grow in pairs or short 
chains (source: http://phil.cdc.gov, picture provided by R. Facklam). 
 
Streptococcus pneumoniae (see Figure 1) was isolated for the first time in 1881. Since then, it has 
been one of the most extensively studied microorganisms ever. Pneumococci belong to the family of 
gram-positive bacteria, and grow in pairs or short chains. The size ranges from 0,5 to 1,25 µm. The 
cocci are surrounded by a polysaccharide capsule. Because of their chemical structure, the capsule 
polysaccharides can be divided into different serotypes. Up to now, 90 different serotypes are 
known, which makes it difficult to develop a suitable vaccine against pneumococci. The pathogenicity 
of pneumocci has been attributed to various structures, most of which are located on its surface. 
However, the high morbidity and mortality caused by this microorganism are still poorly understood 
(AlonsoDeVelasco et al., 1995).  
The most common forms of infections caused by Streptococcus pneumoniae include middle ear 
infections (acute otitis media), lung infections (pneumonia), blood stream infections (bacteremia) 
and meningitis. 
The major ecological niche of S. pneumoniae is the nasopharynx. The carriage rate is highest in little 
children, mainly in their very early stages of life. The risk for nasopharyngeal carriage is higher in 
children less than 6 years of age, children with younger siblings and children with attendance in day 
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care centers. The risk factors for adults are mainly smoking, asthma and acute upper respiratory 
infections (Lynch and Zhanel, 2010). S. pneumoniae causes around 11 % of all deaths among children 
aged 1-59 months (O'Brien et al., 2009). 
2.1.1 Virulence factors 
Virulence factors enable microorganisms to establish themselves within a host and enhance their 
pathogenicity. S. pneumoniae produces several virulence factors which are involved in the illness 
process (see Table 1). 
 
Table 1: Virulence factors of Streptococcus pneumoniae 
(Mitchell and Mitchell, 2010) 
Virulence factor Main contribution to pathogenesis 
Capsule Antiphagocytic activity 
Pneumolysin Pore-formation in cell membranes 
Activation of complement pathway 
LPXTG-anchored surface proteins 
(hyaluronidase, neuraminidase, etc.) 
Breakdown of connective tissue 
Promotion of bacterial spreading 
Promotion of colonization 
Pilus Enhanced binding of pneumococci to cells 
Stimulation of cytokine production 
Lipoproteins Involved in iron uptake 
Enhanced adhesion of S. pneumoniae   
Choline-binding proteins Release of cell wall degradation products and 
pneumolysin 
Promotion of nasopharyngeal colonization 
Providing resistance to complement 
Surface proteins without anchor motifs Mediation of attachment to epithelial cells 
Facilitation of transmigration 
Reduced binding of complement to pneumococci 
Gene and genome variation Resistance to penicillin 
Adaption to changes in environment 
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One group of virulence factors, such as the capsule, provides resistance to phagocytosis and thus 
promotes the escape of pneumococci from the hosts´ immune defense. Other factors, including cell 
wall components and the intracellular toxin pneumolysin, are mainly involved in the inflammation 
caused by an infection. The inflammation process probably fully develops only after lysis of bacteria 
by autolysin, thereby releasing a number of virulence factors (AlonsoDeVelasco et al., 1995). From 
analysis of whole genome sequencing experiments, it is clear that different strains of pneumococci 
differ in their ability to produce virulence factors (Mitchell and Mitchell, 2010). 
2.2 Bacterial meningitis caused by Streptococcus pneumoniae  
Bacterial meningitis is an inflammation of the meninges in response to bacteria and bacterial 
products. It affects the pia mater, arachnoid and subarachnoid space. 
The most common causes of bacterial meningitis nowadays are Streptococcus pneumoniae and 
Neisseria meningitides, because successful vaccination has virtually eliminated Haemophilus 
influenzae type b meningitis. However, mortality and morbidity vary by age and geographical 
location of the patient. Patients at high risk include newborns, those living in low-income countries, 
and immunocompromised people like HIV positives. Today, vaccination strategies have been 
employed with intent to reduce the incidence of pneumococcal meningitis (Brouwer et al., 2010). 
2.2.1 Epidemiology  
Invasive pneumococcal disease occurs, when the Pneumococcus reaches a normally sterile 
compartment like the brain. It most frequently affects children less than 2 years old and adults above 
65 years of age.  
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Figure 2: Streptococcus pneumoniae incidence rate  
Incidence rate per 100,000 children under five years of age, 2000. Countries with resource poor settings are 
mainly affected by the disease (Data source: WHO, 2009). 
 
The risk to suffer from an invasive pneumococcal infection is higher for children in developing 
countries, as they have less access to medical care, and laboratory support, as well as antibiotics are 
hardly available (Lynch and Zhanel, 2010). 
In the developing world morbidity and mortality rates are dramatically higher than in industrialized 
countries (see Figure 2). 
In countries with low medical standard, about 50 % of children with pneumococcal meningitis die 
while in hospital and up to 60 % of survivors suffer from clinical sequelae afterwards (Goetghebuer et 
al., 2000; Muhe and Klugman, 1999). Additional factors, such as HIV infection, malnutrition, and 
antibiotic-resistant bacteria, complicate the management of the infected patients (Scarborough and 
Thwaites, 2008). In comparison, mortality rates of this age group in industrialized countries are about 
10 % and 30 %, respectively (Arditi et al., 1998; Kornelisse et al., 1995). In industrial countries, up to 
60 % of survivors remain with neurological sequelae like seizures, hearing loss or impairment, 
cerebral palsy, learning and memory deficits and mental retardation. The most common sequelae is 
hearing loss. The risk of long-term disabling sequelae is highest in low-income countries, where the 
burden of bacterial meningitis is greatest (Edmond et al., 2010). 
Despite on-going progress in antibiotic therapy and intensive care, the mortality rates, associated 
with invasive pneumococcal disease are among the highest for any major pathogen. Especially 
childhood pneumococcal meningitis remains a devastating disease (Chao et al., 2008). In 1999, the 
Global Alliance for Vaccines and Immunization (GAVI) was formed with the mission of ensuring that 
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every child in the world is protected against vaccine-preventable diseases. This alliance has been 
established to help developing countries to pay for new and underused vaccines and to improve their 
own current immunization services (see http://www.vaccinealliance.org) (Koedel et al., 2002). 
Of particular concern for the clinical management of bacterial meningitis is the rising resistance to 
penicillin and other β-lactam antibiotics (Hoban et al., 2001). 
2.2.2 Pathogenesis 
The main reservoir for Streptococcus pneumoniae is the human nasopharynx. There, it normally leads 
to asymptomatic colonization. The carriage rates are highest among little children (up to 80 %). In the 
general adult population there is a carriage rate of only 4 % (Regev-Yochay et al., 2004). The 
bacterium gets transferred between people by coughing and sneezing. So, in crowded situations, 
such as they occur in hospitals, shelters and prisons, the carriage rate of adults can rise up to 40 % 
(Ihekweazu et al., 2010).  
To colonize and invade the mucosa, bacteria have developed several virulence factors. The invasion 
requires prior adhesion of the pathogen to the endothelial cell surface. Previous studies showed that 
S. pneumoniae initially binds to carbohydrates displayed on epithelial cells, such as galactose beta 1-3 
N-acetylgalactosamine (Gal(ß1-3)GalNAc) and sialic acid (Andersson et al., 1983). 
Colonization of the nasopharynx is supported by further pneumococcal proteins such as the 
neuraminidase NanA and an IgA1 protease. NanA cleaves N-acetylneuraminic acid from mucin, 
glycolipids, glycoproteins and oligosaccharides and can thereby enhance colonization by decreasing 
the viscosity of the mucus or by exposing cell-surface receptors for the pneumococcus (Tong et al., 
2000). 
Also, pneumococci are able to counteract defense mechanisms of the hosts’ immune system. The 
capsule promotes the colonization of the pneumococci and circumvents phagocytosis and activation 
of the complement system, thereby causing bacteremia, which means that bacteria have reached the 
blood stream (Gerber and Nau, 2010). The pneumococcal capsule represents an antigenic 
extracellular layer of polysaccharides, partly concealing the underlying bacterial cell surface from 
recognition by the immune system (Musher, 1992). Also, it has been shown that unencapsulated 
strains of Streptococcus pneumoniae are not able to cause invasive disease (Griffith, 1928). 
After reaching the blood stream, blood circulation enables the bacteria to reach the blood-brain 
barrier, composed of specialized epithelial cells. Cerebral vascular endothelial cells differ from their 
systemic counterparts as they are tightly bound together by tight junctions. Also, they show low 
rates of pinocytosis as well as specific carrier and transport systems. In combination, these properties 
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restrict the non-specific transport of ions, proteins and pathogens into the brain. However, the 
pneumococcus manages to traverse the blood-brain barrier. Ring et al. showed that in human brain 
microvascular endothelial cell cultures, the pneumococci were able to adhere to the platelet-
activating factor (PAF) receptor, enabling the pneumococcus to transmigrate through the endothelial 
cell to the basolateral site (Ring et al., 1998). Another possible mode of action is the disruption of the 
interepithelial tight junctions, enabling the pneumococcus to translocate into the CSF intercellularly 
(Quagliarello et al., 1986). However, it seems that the pneumococcus prefers to cross the blood-brain 
barrier by translocation through the cells rather than between them (Ring et al., 1998). Following the 
activation of the endothelial cell layer, the surface-expression of the PAF receptor is increased. This 
receptor binds phosphorylcholine of the pneumococcal cell wall (Cundell et al., 1995). The PAF 
receptor rapidly gets internalized after binding of a ligand. Accordingly, the pneumococcus seems to 
invade the endothelial cell in a vacuole together with the PAF receptor. Within the endothelial cell, 
the pathogen faces different fates including death within the vacuole and transmigration through the 
cell. Only transparent pneumococci seem to be able to transcytose through endothelial monolayers 
in a significant proportion (Ring et al., 1998). 
The two morphological phenotypes of pneumococci are named opaque and transparent because of 
their appearance on transparent agar surfaces. The differences are the result of a process named 
phase variation. Phase variations are associated with differences in the expression of surface 
determinants that contribute to the ability of the pathogen to interact with the host. Transparent 
variants for example are more suited for colonization and invasion than opaque variants, whereas 
opaque variants show a better survival in the bloodstream. Once in the CSF, the pneumococcus is 
able to survive and replicate because immunoglobulin concentrations in the CSF are low and 
complement components are virtually absent. After reaching the stationary phase of replication (as 
well as in response to antibiotic treatment), autolysis of pneumococci leads to the release of several 
bacterial products (e.g. pneumolysin) that act as stimuli for the release of proinflammatory factors by 
the host. The early response cytokines IL-1, TNF-α, and IL-6 are produced shortly after pneumococcal 
recognition (van Furth et al., 1996). The release of these cytokines is the essential step in a cascade 
of evolving pathophysiologic alterations, including the recruitment of white blood cells into the CSF 
(Tauber and Sande, 1989). 
Despite these early host defenses in the CSF, including recruitment of leucocytes, complement 
components, and immunoglobulins, they don’t seem to be very efficient in phagocytosis of 
S. pneumoniae. One reason for that is the lack of sufficient complement concentrations to achieve 
opsonic activity (Simberkoff et al., 1980; Stahel et al., 1997). Although the concentrations of IgG 
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increase during the course of bacterial meningitis, they also seem to remain below the 
concentrations which are required for an optimal opsonic activity (Smith and Bannister, 1973). 
2.2.3 Diagnosis and Treatment 
The survival of a patient suffering from invasive pneumococcal disease is dependent on rapid 
diagnosis and early treatment. 
Pneumococcal diseases are basically treated with antibiotics. Since the resistance of bacteria towards 
antibiotics is rising, there is an urgent need to develop suitable vaccines to prevent infections. 
However, in some populations, resistance to antibiotics still remains a problem. 
Another problem of antibiotic therapy is that killing the bacteria can lead to a massive release of 
biologically active bacterial products (like bacterial toxins and cell wall components) that potentiate 
inflammation and other pathophysiologic alterations (Tauber et al., 1987). 
Over the past years, extensive research in the field of bacterial meningitis showed that neuronal 
damage after recovery of the disease is generally mediated by a severe inflammatory response of the 
host (Scheld et al., 2002). The hosts’ immune system responds to bacterial toxins, cell wall 
components and cell lysis products, thereby perpetuating the inflammatory process. These findings 
led to new therapeutic approaches like the use of non-bacteriolytic antibiotics and the suppression of 
inflammation. For this purpose, corticosteroids like dexamethasone seemed to be the best choice as 
adjunctive anti-inflammatory treatment (Koedel et al., 2010). 
Dexamethasone acts as an anti-inflammatory and immunosuppressive agent. It is recommended for 
adjunctive therapy of pneumococcal meningitis, as it reduces many of the pathophysiologic 
consequences of the disease. It down-modulates also many of the events that follow the initiation of 
antibiotic therapy (Tauber et al., 1985). However, a metaanalysis of 5 large recent trials of adjunctive 
dexamethasone, including more than 2000 participants, showed no effect of dexamethasone 
concerning the reduction in mortality and only slight effects in the reduction of hearing loss among 
the survivors (van de Beek et al., 2010).  
Although some benefit of adjunctive dexamethasone therapy might be confined to patients with 
pneumococcal meningitis in high-income countries (McIntyre, 2010), in areas of the world where 
access to quality care is limited, the use of pneumococcal vaccine is particularly necessary to limit 
disease and save lives. 
At present, strategies to prevent and treat bacterial meningitis are constrained by an incomplete 
understanding of the pathogenesis. Therefore, further research on meningitis pathogenesis is 
needed (Kim, 2010). 
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2.3 Pneumolysin 
 
 
 
Figure 3: Proposed protein structure of PLY 
The configuration of the toxin monomer is fitted to perfringolysin O. Pneumolysin is arranged in four 
structural domains. Domain 1 serves as a scaffold, domain 2 plays a role in the transformation process 
from prepore to the final pore, domain 3 is responsible for the penetration of the membrane and 
domain 4 is essential for the binding of the toxin to membrane cholesterol  (Rossjohn et al., 2007). 
 
Pneumolysin (PLY, see Figure 3) is one of the major virulence determinants of Streptococcus 
pneumoniae. PLY is a 53 kDa protein which belongs to a large family of highly homologous bacterial 
toxins; the so-called cholesterol-dependent cytolysins (CDCs). The activity of all family members 
takes place at membranes, but the proteins themselves are involved in diverse phenomena. The 
CDCs for example also include human proteins, like perforin and the membrane attack complex. PLY 
is expressed by almost all clinical isolates of S. pneumoniae during the late log phase of growth. It is 
located in the cytoplasm of the bacteria and mainly gets released when the pneumococci undergo 
autolysis (Paton, 1996). However, more recent studies show that Streptococcus pneumoniae also can 
release PLY independently of autolysis mediated by autolysin (Balachandran et al., 2001). 
Pneumolysin is composed of 471 amino acids, arranged in four structural domains. The main effects 
of PLY on the host are mediated by two modes of action: the binding to the cell membrane, followed 
by pore formation, and the activation of the complement pathway in a non-immunospecific manner 
through direct interaction with the IgG domain Fc  (Mitchell et al., 1991; Rossjohn et al., 1998). 
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The attachment of pneumolysin to the cell membrane is dependent on the cholesterol in the 
membrane. The binding to cholesterol is rapid, dependent on the pH but independent of 
temperature (Johnson et al., 1980). In 2004, Nollmann et al. showed that the haemolytic activity of 
pneumolysin could be anticipated by cholesterol and that the stoichiometry of the cholesterol-PLY 
complex is 1:1 (Nollmann et al., 2004). 
Up to now, there is no model of the pneumolysin molecule in solution available, just low-resolution 
images from electron microscopy (Gilbert et al., 1998; Morgan et al., 1995). Pneumolysin shows high 
homology to perfringolysin O (PFO, a protein toxin produced by clostridium perfringens) as it has 
almost the same molecular mass and shares 48 % sequence identity with PFO. Therefore it has been 
possible to build a model for PLY, based on the homology with perfringolysin O, for which an atomic 
structure has been established (Solovyova et al., 2004). 
2.3.1 Contribution of PLY to the virulence of S. pneumoniae 
Pneumolysin plays a crucial role in the pathogenesis of pneumococcal meningitis, as mutant strains 
of S. pneumoniae which do not express pneumolysin, showed reduced virulence in a rat model of 
meningitis (Hirst et al., 2008; Reiss et al., 2011).  
Using a microvascular endothelial cell culture model, it has been shown that pneumococci expressing 
pneumolysin were able to traverse the endothelial cells, whereas mutant pneumococci deficient in 
pneumolysin were unable to penetrate the cell barrier (Zysk et al., 2001). In 2000, Hirst et al. have 
shown that pneumolysin is toxic to ciliated ependymal cells, and that PLY inhibits ependymal ciliary 
beat frequency (Hirst et al., 2000a; Hirst et al., 2000b). There are several other biological effects of 
pneumolysin, like the lysis of red blood cells, the increase of alveolar permeability in rat lung, the 
inhibition of mitogen induced proliferation and antibody production by human lymphocytes as well 
as electrophysiological and histological damage after perfusion into the cochlea of guinea pigs 
(Mitchell and Andrew, 1997). 
A major activity of pneumolysin is activation of complement via the classical pathway in absence of 
specific antibody (Paton et al., 1984). Additionally, it has been shown that pneumolysin is thereby 
able to decrease the opsonization of pneumococci (Yuste et al., 2005). Domain 4 of the protein toxin 
shows a structure similarity to the Fc portion of immunoglobulin (Gilbert et al., 1998). The ability of 
PLY to activate the complement pathway is probably due to nonspecific binding of the Fc portion of 
IgG by the toxin (Mitchell and Andrew, 1997). 
Despite all these dramatic effects of pneumolysin, it is also able to induce mild damage to cells. It has 
been shown, that pneumolysin, in sub-lytic concentrations, leads to a phosphorylation of p38 MAPK 
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in epithelial cells. That seems to be a conserved response of epithelial cells to sub-lytic 
concentrations of bacterial pore-forming toxins, thereby acting as an early warning system to initiate 
an immune response while the local density of toxin-producing bacteria is still low (Ratner et al., 
2006). 
2.3.2 Pore formation process 
For the pore formation process of CDCs, two mechanisms have been proposed. One suggests that 
the toxin inserts into the bilayer in its monomeric form, then assembles into oligomers and forms a 
pore (Morgan et al., 1994). According to the second, most favored theory, the toxin binds to the lipid 
bilayer, oligomerizes to form a pre-pore, which then inserts into the cell membrane (Tilley et al., 
2005). 
By studies of Gilbert et al. and Tilley at al., structures for the prepore complex, as well as for a fully 
inserted membrane pore have been introduced (Gilbert et al., 1999b; Tilley et al., 2005). By applying 
the structural findings of perfringolysin O to these structural findings of the pore complexes, the 
different conformational changes of the proteins during pore-formation have been proposed.   
 
 
 
Figure 4: Pore formation process of pneumolysin  
The pore forming process by pneumolysin takes place in several steps. Firstly, domain 4 binds to membrane 
cholesterol (A). By rising concentrations of pneumolysin, the toxin monomers assemble and oligomerize (B). 
By conformational changes, the α-helices in  domain 3 transform into ß-hairpins, which then poke into the 
membrane, leading to the final pore (C) (Walz, 2005). 
 
It has been shown, that the C terminal domain (domain 4) of pneumolysin is critical for the binding to 
cholesterol in cell membranes (Owen et al., 1994). The most conserved region in the cholesterol-
binding sequence is the tryptophan (Trp) rich loop at the base of domain 4. This loop is responsible 
for entering the membrane (Gilbert et al., 1999), as the modification of the single cysteine in this Trp 
rich loop prevents PLY from binding to lipid bilayers (Gilbert et al., 1999a). It has been shown, that 
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direct binding of domain 4 of pneumolysin to membrane cholesterol is an essential step to exert lytic 
activity (Baba et al., 2001). Domain 1 serves as a scaffold, stabilizing the protein structure and 
allowing the other domains to rearrange around. When the concentration of pneumolysin rises, the 
monomers begin to assemble into oligomers, which needs the help of domains 1 and 3. The 
oligomerization process leads to a change in the orientation of domains 2 and 4 towards each other, 
thereby bending domain 2, leading to a loss of contact between domains 2 and 3. When domain 2 is 
completely detached from domain 3, the transformation from the prepore state to the final pore 
takes place (see Figure 4). Therefore, domain 3 moves towards the inner surface of the developing 
prepore complex. By this conformational change, the α-helices in domain 3 transform into ß-hairpins. 
A final bending of domain 2 moves domain 3 closer to the membrane leads to a poking of the ß-
hairpins into the membrane, thereby forming the final pore (Gilbert et al., 1999b; Shatursky et al., 
1999; Tilley et al., 2005). 
2.1 Cellular components of nervous tissue 
2.1.1 Neurons 
Neurons (see Figure 5) are the basic working units of the brain. During their development, they 
emerge a highly polarized morphology which enables them to quickly transmit information to other 
nerve cells, muscle or gland cells. The brain contains between 1 billion and 100 billion neurons, 
depending on the species. 
 
 
 
Figure 5: Neuron 
Neurons are highly specialized cells. During development, they alter their morphology to become highly 
polarized cells, enabling them to quickly transmit information. 
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Morphologically, the neuron is divided into three major regions: a cell body (perikaryon), containing 
the nucleus and most organelles; dendrites, emerging from the neuronal cell body and a single 
excitable axon, which extends from the perikaryon and often splits up into smaller branches before 
ending at nerve terminals.  
Many axons in the brain are covered with an insulating myelin sheath composed of oligodendrocytes, 
enabling the axon to spread the electric signal very fast along. In the peripheral nervous system, this 
sheath is made of Schwann cells. 
Neurons send signals by transmitting electrical impulses along their axons. The electric signal is 
created by a difference in charge between the inner and the outer side of the cell membrane. This 
transmembrane potential difference is generated by the opening and closing of ion channels, which 
regulate the flow of ions through the membrane. The flow of these ions creates an electrical current 
that produces small voltage changes across the neuron´s cell membrane.  
A nerve pulse arises, when a reversal in the membrane potential occurs at one point of the cell 
membrane. Then, the neuron´s internal negative charge switches to a positive charge state. This 
change is called action potential. The action potential then spreads along the axon at high speed. 
Axons contain several unmyelinated patches, the so-called nodes of Ranvier. These spots boost the 
signal by propagating the signal from one to another (saltatory conduction). In this way, neurons are 
able to fire impulses multiple times every second. 
By reaching the end of the axon, the signal triggers the release of neurotransmitters into the synaptic 
cleft. Neurotransmitters are the chemical messengers of the brain. After getting released into the 
synaptic cleft, these transmitters diffuse across the intrasynaptic space, reaching the postsynaptic 
membrane, where they bind to specific receptor molecules on the surfaces of adjacent cells (other 
neurons, muscle or gland cells). The so-called dendritic spines resemble the postsynapses, where 
neurons receive input from the axons of other neurons. The receptor molecules on the postsynaptic 
membrane act as on-and-off switches for the next cell. Each receptor has a region that selectively 
recognizes a particular neurotransmitter. When the transmitter is connected to its receptor, this 
interaction alters the target cell’s membrane potential and subsequent depolarization of this target 
cell leads to a further propagation of the signal. Increased understanding of neurotransmitters and 
signaling in the brain and the understanding how drugs can modulate these processes guides one of 
the largest fields in neuroscience (Squire, 2008).  
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2.1.2 Neuroglia 
1859 introduced by Rudolph Virchow, the term neuroglia describes the connective tissue in the 
brain. There are 4 different types of neuroglia cells in the CNS of vertebrates: oligodendrocytes, 
astrocytes, microglia and ependymal cells. 
Astrocytes, as one major subtype of glial cells, appear in many shapes and forms, although they are 
mostly star-shaped. They represent up to 50 % of the cells in the brain. Astrocytes are connected to 
each other via gap junctions. They strengthen the blood-brain barrier by inducing and maintaining 
the tight junctions between the epithelial cells which form the barrier. These highly specialized cells 
are the main reservoir for extracellular matrix proteins and adhesion molecules in the CNS (e.g. 
laminin and fibronectin). They also produce a large number of growth factors and cytokines, thereby 
contributing to the developmental function and regenerative capacity of the brain (Squire, 2008). 
Although for a long time they seemed to be only connective tissue in the brain (“brain glue”), 
research in the past years revealed they contribute to a lot of important functions in the brain. For 
example, it has been shown that astrocytes play eminent roles in neuronal signaling and in several 
diseases of the brain. They have been ignored in science for a long time, because their mode of 
action is more subtle and in an indirect manner (Ransom et al., 2003). Astrocytes are generally 
considered as nonexcitable cells. However, recent studies showed that astrocytes interact with 
neurons via calcium signaling (Nag, 2011). It has also been shown, that astrocytes can release 
glutamate themselves in response to elevated intracellular calcium levels (Parpura et al., 1994).   
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Figure 6: Schematic of the tripartite synapse 
The latest model of synapses involves astrocytes in the complex mechanism of synaptic transmission. 
They ensheath prae- and postsynapse, thereby supporting the whole process of neuronal signaling (Allen 
and Barres, 2009). 
 
This bidirectional communication between astrocytes and neurons is a quite recent topic in synapse 
research and has led to the term “tripartite synapse” which means the involvement of  presynaptic 
neurons, postsynaptic neurons and astrocytes in synaptic transmission (see Figure 6), not only the 
involvement of two neurons, as it has been believed for a long time. The appearance of astrocytes at 
synapses enables them to monitor and to respond to synaptic activity (Allen and Barres, 2009). 
2.1.3 The glutamate-glutamine cycle 
One of the most important functions of astrocytes in the brain is the uptake of the neurotransmitter 
glutamate secreted by neurons and its recycling back into neurons. This process is termed glutamate-
glutamine cycle (see Figure 7). Thereby it is ensured, that the balance of glutamate in the CNS is 
stable. 
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Figure 7: The glutamate-glutamine cycle 
To ensure a balance of glutamate concentration in the brain, astrocytes take up the released 
glutamate, convert it into glutamine which is then taken up by neurons, which can then convert it 
back into glutamate (Sanacora et al., 2008). 
 
Neurons are not able of a de novo synthesis of the neurotransmitter glutamate. Also, the blood-brain 
barrier bans serum glutamate from entering the CNS, and as a consequence, all brain glutamate has 
to be synthesized within the brain itself. So, neurons depend on astrocytes, which release glutamine 
as a precursor of glutamate (Bak et al., 2006).  
After the release of glutamate through neuronal signaling, the ensheathing astrocytes (as a part of 
the tripartite synapse, see chapter 2.1.2) eliminate glutamate from the synaptic cleft by excitatory 
amino acid transporters (EAATs). Afterwards, glutamate reacts with ammonia to form glutamine 
through the activity of glutamine synthetase (a cytosolic, ATP-dependent enzyme, which is not 
expresses by neurons). This reaction is also important because of the fact that it detoxificates free 
ammonia. Glutamine then is secreted into the extracellular fluid. The release of glutamine into the 
synaptic cleft is uncomplicated, as glutamine has no transmitter activity. In neurons, glutamine is 
converted back into glutamate by the phosphate-activated mitochondrial enzyme glutaminase or by 
transamination of 2-oxoglutarate, an intermediate in the citric acid cycle (Hertz et al., 1999).  
Synaptic glutamate is accumulated in vesicles. Each vesicle contains approximately 1200 molecules of 
glutamate. The accumulation of the transmitter is caused by specialized proteins in the vesicular 
membrane, the vesicular glutamate transporters (VGLUTs). After release of the vesicles, the cycle 
restarts. At GABAergic synapses, the cycle is called GABA-glutamine cycle, respectively (Siegel, 2006). 
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Interestingly, astrocytes also express a lot of the neurotransmitter receptors appearing on the cell 
membranes of neurons. Release of transmitters by neurons therefore leads to an intracellular 
calcium rise in astrocytes, triggering the release of several neuroactive compounds, thereby signaling 
back to the neurons. This interaction either leads to an enhancement or an inhibition of neuronal 
activity. Additionally, these highly specialized cells are able to communicate with each other through 
calcium waves (Allen and Barres, 2009). Quite recent experiments showed that human astrocytes 
also express NMDA receptors (Lee et al., 2010). 
2.2 Excitotoxicity 
Over the past several years, research has demonstrated that excitatory amino acids serve as the 
major excitatory neurotransmitters in the cerebral cortex and hippocampus. Neurons that contain 
excitatory amino acids play crucial roles in psychological functions such as learning and memory 
(Dong et al., 2009). 
The term “glutamate excitotoxicity” was introduced by Olney, who described intracranial brain 
lesions in response to subcutaneous injections of glutamate in infant and adult mice (Olney, 1969). 
Excitotoxicity is defined as cell death resulting from the toxic actions of excitatory amino acids. 
Because glutamate is the major excitatory neurotransmitter in the mammalian central nervous 
system, neuronal excitotoxicity usually refers to the injury and death of neurons arising from 
prolonged exposure to glutamate and the associated excessive influx of ions into the cell. The 
resulting calcium overload is particularly neurotoxic, leading to the activation of enzymes that 
degrade proteins, membranes and nucleic acids. For instance, Ca2+ -activated proteolytic enzymes 
(e.g. calpains) can destroy essential proteins. High intracellular calcium levels also activate the 
Ca2+/calmodulin kinase II (CaMKII), leading to a phosphorylation of several enzymes, thereby 
increasing their activity (Berliocchi et al., 2005). 
Overactivation of glutamate receptors impairs cellular calcium homeostasis and activates nitric oxide 
synthesis, generation of free radicals and programmed cell death (Sims and Zaidan, 1995). 
Acute CNS insults such as ischaemia and traumatic brain injury have traditionally been the focus of 
excitotoxicity research. However, glutamate excitotoxicity has also been linked to chronic 
neurodegenerative disorders such as amyotrophic lateral sclerosis, multiple sclerosis, Parkinson’s 
disease and others. Despite the continued research into the mechanisms of excitotoxicity, there are 
currently no pharmacological interventions capable of providing significant neuroprotection in the 
clinical setting of brain ischaemia or injury (Lau and Tymianski, 2010). 
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The mechanisms underlying glutamate excitotoxicity are complex. However, especially in the acute 
pathologies, glutamate excitotoxicity is not a result of a genetic mutation or structural deficit in the 
channel. Instead, glutamate excitotoxicity can be thought of as a normal physiological response to a 
CNS insult. Chronic over-excitation of neurons elicited by glutamate is a newer concept that has 
linked glutamate excitoxicity to neurodegenerative processes in ALS, Huntington’s disease, 
Parkinson’s disease and Alzheimer’s dementia (Lau and Tymianski, 2010). 
2.2.1 Glutamate receptors 
Glutamate receptors are mainly synaptic receptors, distributed throughout the central nervous 
system. They are divided into two classes: ligand gated ion channels (ionotropic receptors; iGluRs) 
and G-protein coupled channels (metabotropic receptors; mGluRs). The class of ionotropic glutamate 
receptors is composed of NMDA-, AMPA-, and kainate receptors, whereas the metabotropic 
glutamate receptor family includes 8 different receptors (mGluR1-8). Glutamate receptors are 
involved in neuronal communication, memory and learning processes. Furthermore, they play a role 
in the pathogenesis of some neurodegenerative disorders, like dementia and Alzheimer´s disease.  
2.2.1.1 NMDA receptors 
Of all the glutamate receptors known up to now, the N-methyl-D-aspartate receptor (NMDAR) is the 
most studied. It belongs to the group of ionotropic glutamate receptors. N-methyl-D-aspartate is the 
name of the compound that selectively activates the NMDAR. NMDARs are cation-channels that are 
highly permeable to calcium ions. They are involved in multiple brain activities, like learning and 
memory, as they are essential for the regulation of synaptogenesis and long-term plasticity changes 
in synaptic strength. The stimulation of NMDARs may be beneficial, but excessive stimulation, 
followed by rising intracellular calcium concentrations, causes the activation of intracellular 
pathways leading to both physiological (e.g. learning and memory) and pathological processes (e.g. 
excitotoxic injury) (Benarroch, 2011). 
NMDARs are large heteromeric complexes composed of four homologous subunits derived from 
three related families: NR1-3. According to the current proposed nomenclature, these subunits are 
termed GluN1, GluN2, and GluN3, respectively. Because of these manifold possibilities of NMDA 
receptor composition, NMDARs exist as diverse subtypes with distinctive patterns of expression 
(Paoletti, 2011). The NMDAR exhibits a complex gating mechanism, requiring not only binding of 
various ligands but also cellular depolarization. The depolarization is necessary to remove a 
magnesium ion from inside the channel which normally blocks the NMDA receptor (Lau and 
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Tymianski, 2010). When activated, the NMDAR allows the influx of cations, though most notably 
calcium. Because of their involvement in several neurological disorders like Alzheimer´s and 
Parkinson´s disease, NMDARs are of course also targets of therapeutic interest. The development of 
drugs to block or stimulate NMDA receptors to treat neurological and psychiatric disorders is of 
particular interest. 
2.2.2 Inhibitors 
Since the association of glutamate excitotoxicity with several neurological diseases, various attempts 
have been made to attenuate neuronal damage by glutamate receptor function. The NMDAR itself 
has a number of sites to manipulate pharmacologically, including the ion channel pore, the 
glutamate-binding site, the glycine-binding site and the polyamine interaction site. Antagonists of the 
NMDA subclass of glutamate receptors may offer new approaches for the prevention and treatment 
of ischemic brain injury. This strategy is supported by encouraging results in a variety of in vivo and in 
vitro experimental models (Albers et al., 1989). 
2.2.2.1 MK-801 
 
HN
 
Figure 8: Chemical structure of MK-801 
MK-801 is a potent inhibitor of NMDA receptors. 
 
(+)-5-methyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5,10-iminemaleate (dizocilpine; MK-801, 
see Figure 8) originally had been invented as an anticonvulsant. Later studies using a cortical slice 
preparation revealed that MK-801 is a potent, non-competitive antagonist of N-methyl-D-aspartate 
(NMDA)-induced depolarization. In these experiments, MK-801 was able to block responses to NMDA 
and quinolinic acid but had no effect on responses produced by kainic acid or quisqualic acid. 
Another effect of the compound was, that MK-801, parenteral administered, showed 
neuroprotective effects. It also caused complete protection against loss of neurons produced by 
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injection of neurotoxic doses of NMDA or quinolinic acid into the striatum or hippocampus 
(Woodruff et al., 1987). 
However, dizocilpine was not approved for human use, for it had cardiovascular side effects and in 
behavioral studies using a variety of species, including rhesus monkeys, appeared to have the same 
psychotomimetic properties as phencyclidine (PCP; “angel dust”) (Koek et al., 1988). MK-801 blocks 
the NMDAR at the level of the channel pore, thereby reducing calcium entry. 
2.2.2.2 AP5 
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Figure 9: Chemical structure of AP5 
AP5 serves as a competitive NMDA receptor antagonist. 
 
AP5 (2-amino-5-phosphonopentanoic acid, see Figure 9), in contrast to MK-801, is a competitive 
NMDA receptor antagonist. It selectively blocks the NMDA receptor by binding to the same site 
glutamate is binding. AP5 can block depolarization induced by NMDA but is ineffective against 
kainate and quisqualate-induced depolarization. This NMDAR antagonist blocks the induction of 
sustained depolarization by high-frequency stimulation as well as the propagation of epileptiform 
discharges in hippocampal slices (Herron et al., 1986). AP5 is able to block hippocampal long-term 
potentiation (LTP) in vivo, without effecting normal synaptic transmission (Morris, 1989). 
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3  
3.1 Pneumolysin expression and purification 
Pneumolysin and mutants were kindly provided by Prof. Timothy Mitchell, Institute of Infection, 
Immunity and Inflammation, University of Glasgow. 
PLY was prepared as follows. The toxin was expressed in E.coli XL-1 cells and purified by hydrophobic 
interaction chromatography as described in Mitchell et al., 1989. The lipopolysaccharide (LPS) 
content of purified toxin was determined by using the Limulus Amebocyte Lysate Kinetic-QCL Kit. All 
purified proteins had <0.6 endotoxin units/μg of protein. The purified wild-type toxin had an activity 
≈5 x 104 hemolytic units/mg. One hemolytic unit was defined as the minimum amount of toxin 
needed to lyse 90 % of 1.5 x 108 human erythrocytes per ml within 1 h at 37 °C. The non-toxic delta6 
version of the plasmid was constructed by site-directed mutagenesis (Mitchell et al., 1989). 
3.2 Cell culture 
All animal experiments were performed according to the regulations of the German Protection Law 
with approval from the Government of Lower Franconia, Bavaria, Germany.   
3.2.1 Primary neuronal culture 
To obtain optimal growth of the cells on the cell culture slides/dishes, they have to be coated prior to 
the seeding of the cells. Therefore, the dishes and slides get incubated overnight with a solution of 
Poly-L-ornithine (PLO) in an incubator at 37 °C. To prepare a culture of primary hippocampal cells, we 
used C57BL/6 mice at day 13 of gestation (E 13). 
Firstly, the mother C57BL/6 mouse is killed by vertebral dislocation. Then, the abdomen skin is cut in 
the sagittal line without opening the peritoneum. After administering alcohol all over, the 
peritoneum is cut, the uterus bicornus gets extracted and the vessels are cut by scissors. The 
embryonic sacs get instantly transferred into a sterile petri dish, filled with chilled PBS on ice. The 
embryonic sacs are then cut in the area opposite to the placenta; thereby the embryos easily drop 
out. The heads are cut off and immediately transferred into another petri dish, filled with PBS on ice. 
While fixing the skull with sharp forceps through the eyes, the heads are cut in the midline, using 
micro scissors. The skin and the lamina are pushed aside with sharp forceps. Pushing from beneath 
the brain with a small spoon, the brain can easily be pulled outside the skull. The brains immediately 
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get placed in chilled, sterile PBS on ice. Firstly, the cerebellum and brain stem have to be removed. 
Secondly, the brain is cut in two halves. By using forceps, the meninges can be removed from the 
cortex with caution.  
From each hemisphere, the hippocampus gets removed by cutting the hemispheres from beneath. 
The hippocampi are then collected in 7 ml chilled PBS in a 15 ml falcon tube. By pipetting up and 
down several times, the cells get dispersed. The cell suspension then is centrifuged at 4 °C and 
1500 rpm for 5 minutes. After removal of the PBS, the cells get resuspended in cell cuture medium 
(Basal Medium Eagle (BME), supplemented with 1 % FCS, 1 % Glucose, 1 % Penicillin/Streptomycin 
and 2 % B-27). Prior to seeding, the vital cells get counted by placing 20 µl cell suspension, diluted 1:1 
with a 0,4 % solution of trypan blue in a Neubauer cell counter under a stereomicroscope. 
The cell suspension is adjusted to 150.000 vital cells per ml and seeded in cover slip bottom chamber 
slides (1 ml cell suspension per chamber) for live cell imaging and in permanox chamber slides for 
immunocytochemistry. 
After a few days without changing the medium, the cells begin to interconnect and establish 
synapses. Two weeks after seeding, the neurons build up a network with a lot of established 
synapses. Then, they are ready for experiments. 
3.2.2 Primary astrocytic culture 
As culture medium for primary astrocytes, we use Dulbecco's Modified Eagle Medium (DMEM) 
GlutaMax high glucose, supplemented with 10 % fetal calf serum (FCS) and 
1 % penicillin/streptomycin).  
The astrocytes are prepared from C57BL/6 mice at postnatal day 6 to 7 (PD 6-7). The pubs get killed 
by decapitation. After distribution of alcohol all over the skull, the skin is removed from the cranium 
and kept aside. The skull gets cut along the middle line with small scissors. The brain is then removed 
by using a small spoon, pushing from beneath. After chopping off the cerebellum, the meninges get 
removed. The brains are cut in two halves and collected in chilled PBS in a small falcon tube (15 ml) 
on ice. By pipetting up and down, the tissue gets disrupted. The brain suspension is then centrifuged 
at 4 °C and 1600 rpm for 5 minutes. The PBS gets replaced by culture medium and the cells are 
resuspended by several times of pipetting up and down. Per 75 cm2 culture flask, 2 brains are 
sufficient. The cells are seeded onto culture flasks which were previously coated with PLO (see 3.2.1). 
The cells grow in monolayer. To obtain optimal growth, the medium is replaced by fresh medium 
every two days.  
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For seeding, the cells get washed once with PBS before getting trypsinated by adding 2 ml of 0.05 % 
EDTA Trypsin into a cell culture flask with astrocytes.  After 10 - 12 minutes incubation at 37 °C, 5 % 
CO2 and 95 % humidity, the trypsin is inactivated by adding 8 ml fresh culture medium. The cells can 
be harvested by flushing them several times with medium. Afterwards, they get collected in a 15 ml 
falcon tube on ice. After a centrifugation step (4 °C and 1600 rpm for 5 minutes), the medium is 
replaced by fresh medium and the cell pellet can be resuspended by several times of pipetting up 
and down. The cells are then seeded at a density of 200 000 cells/ml.  
3.3 Brain slice culture 
3.3.1 Theory 
The advantages of brain slices over primary culture are multiple: Brain slices remain the tissue 
architecture of the brain regions they are generated from. Also, they represent a high similarity to 
the in vivo situation, as the neuronal activities and circuits remain functional in the tissue context.  
Organotypic slice cultures are typically prepared from mice at postnatal days 3-9. At this age, they 
have a high degree of plasticity and resistance to mechanical trauma during the slice preparation. 
Also, basic synaptic connections have been established, particularly in the CA1 area of the 
hippocampus; but mature synapses have not yet been established in the brain. They usually develop 
during the following 2-3 weeks in vivo (Cho et al., 2007). 
For experiments, we used mice at PD 6-7 and PD 14-15, to compare toxin effects between different 
stages of development. 
3.3.2 Preparation 
For the preparation of acute brain slices, the mouse gets killed by decapitation. After administering 
some ethanol, the brain is removed by cutting the scalp with small scissors. The soft skull then gets 
opened with scissors. Afterwards, the cranial plates are removed by small forceps. Then the whole 
brain gets detached by pushing from beneath with a small spoon. After transferring the brain into 
chilled PBS on ice, the cerebellum is cut off by a scalpel. The cerebrum is placed on top of a specimen 
holder and gets stuck there by adhesive bonding. The specimen holder is then positioned in a cooled 
container filled with chilled and carbogenated artificial cerebrospinal fluid (ACSF). During the whole 
cutting process, the ACSF is constantly gassed with carbogen. The brain gets sliced up by coronal 
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sectioning with a vibratome, starting from a position 5 mm rostral from the olfactory bulb up to 
9 mm, cutting the brain into 300 µm thick slices.  
Prior to incubation with toxin, the slices are allowed to adapt at 37 °C for 30 minutes in carbogenated 
BME, supplemented with 1 % glucose and 1 % penicillin/streptomycin. Subsequently to toxin 
challenge, the brain slices get fixed in a 37 °C preheated solution of paraformaldehyde (PFA). 
3.4 Transfection of primary neurons 
To investigate single neurons by live cell fluorescence imaging approaches, it is inevitable to use a 
transfection method which shows low toxicity and long-lasting protein expression. As neurons 
(especially in culture) are sensitive to cytotoxicity and difficult to transfect with most methods, we 
used the MagnetofectionTM approach for gene transfer. This method is cost-effective, easy to 
perform and does not require the preparation of complex constructs, such as viruses, which are 
known to be widely used for gene delivery into neurons (Buerli et al., 2007) 
3.4.1 Theory 
Transfection is a method to integrate DNA into eukaryotic cells. There are several methods for 
transfection existent. The principle of MagnetofectionTM is to attach the DNA of interest to magnetic 
nanoparticles coated with cationic molecules.  
 
 
 
 
Figure 10: Principle of MagnetofectionTM 
With the help of this method, the DNA of interest gets attached to magnetic beads. During 
incubation on top of a magnetic plate, the DNA gets transfected into the cell by magnetic force. 
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The DNA couples to the magnetic beads by salt-induced colloidal aggregation and electrostatic 
interaction. The magnetic beads then directly get applied onto the cells. By putting the culture plates 
on top of a magnetic plate, the beads (with the DNA attached on their surface) get traversed through 
the cells by magnetic force, leaving the DNA in the cytoplasm of the cells (Scherer et al., 2002).  
The method is very mild towards the cells, which makes it a suitable application for the vulnerable 
primary neurons. The membranes of the transfected cells stay intact which represents an advantage 
over other physical transfection methods. Another advantage is that per each well, just a few cells 
get transfected. As the transfected gene in our case encodes the green fluorescent protein (GFP), it is 
possible to observe single neurons in a high magnification to follow how they change under several 
conditions. 
3.4.2 Procedure 
For live cell imaging, the cells are seeded onto chambered coverglass slides in a concentration of 
150 000 cells/chamber.  
At DIV (days in vitro) 10-12, the cells are dense enough and ready for transfection. First of all, the 
NeuroMagTM reagent has to be vortexed. Per 1 µg DNA (Plasmid: pSyn-NGFP) 1 µl transfection 
reagent is sufficient. The transfection solution is prepared as follows. For each slide (4 chambers) to 
be transfected, 100 µl BME medium without serum is placed in a small vial. Then 4 µg (1 µg per 
chamber) of plasmid DNA is added, before adding the NeuroMagTM reagent. All is mixed by vigorous 
pipetting and incubated at room temperature for 20 minutes. Afterwards, the mixture is filled up to 
400 µl with BME medium, briefly vortexed and 100 µl per chamber is added to the cells. The slide is 
then placed on top of the magnetic plate during 15 minutes. After removing the plate, the cells are 
cultivated at 37 °C in a CO2 incubator until evaluation of GFP expression, which takes approximately 
24 hours.         
Prior to observation, medium gets exchanged by a clear live cell imaging buffer, to avoid disturbances 
of fluorescence by phenol red. The microscope is improved by a heating chamber and a heating plate 
to remain temperature at stable 37 °C.  
In each chamber, one transfected (thereby glowing in a light, green manner), healthy neuron is 
selected for observation.  
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3.4.2.1 Multiplication of the plasmid 
To replicate the plasmid DNA, Escherichia coli DH5α cells were used for transformation. This E. coli 
strain represents a chemically competent bacterial strain, which means, the cells are able to take up 
naked DNA by a heat shock. 
The cells get thawed on ice for about 15 minutes. After agitating with caution, 50 ng plasmid DNA per 
approach is used and mixed with the cells carefully. The cells are then incubated for 30 minutes on 
ice. To transverse the DNA into the cells, they get a heat shock at 42 °C for 1,5 minutes in a water 
bath. After putting the cells on ice for another 1,5 minutes, 900 µl LB (Lysogeny broth) medium per 
approach is added. For 1 h, the cells are then mixed at 37 °C and 400 rpm in a thermomixer. The cells 
afterwards get centrifuged at 4 °C and 6 000 rpm for 3 minutes. 800 µl of the supernatant gets 
discharged, the rest is resuspended. The cells (100 µl cell suspension) then are plated onto ampicillin 
containing agar plates, because the plasmid features an ampicillin resistance gene. Thus it is ensured, 
that only bacteria which incorporated the plasmid grow on the agar plates. For optimal growth, the 
plates are kept at 37 °C in an incubator overnight. The next day, the colonies can be picked. Each 
colony is placed in a 5 ml tube filled with LB medium containing 100 µg/ml ampicillin. After 12 hrs 
shaking at 37 °C, the bacteria culture are processed by using the Quiagen Miniprep kit which is used 
according to manufacturer´s instructions. The gained plasmid DNA is stored at -20 °C until usage.        
3.5 Cytotoxicity assay 
3.5.1 Theory 
To measure cytotoxicity in brain slice culture medium or in the supernatant of cell culture, the lactic 
dehydrogenase assay is the method of choice.  
When cells get destroyed or damaged, their cell membranes get loosen up. When the cell 
membranes are disrupted, the enzyme lactic dehydrogenase (LDH) leaves the cytosol and gets 
transferred into the extracellular space.  
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Figure 11: Lactic dehydrogenase reaction 
Lactic dehydrogenase (LDH) is released by damaged cells. This enzyme reduces pyruvate to lactate under 
consumption of NADH. By measuring the decrease of NADH, one can calculate the correlating cell death in the 
supernatant of cell culture, e.g. 
 
LDH reduces pyruvate to lactate under consumption of reduced nicotinamide adenine dinucleotide 
(NADH) (see Figure 11). NADH, in contrast to the oxidized form NAD+, has a second absorption peak 
at 340 nm. By measuring the decrease of the absorption at 340 nm with a photometer, one can 
conclude the amount of lactic dehydrogenase in the culture medium, which correlates with cell 
death (Moran and Schnellmann, 1996). 
3.5.2 Procedure 
For measuring LDH in the supernatant, the medium gets collected subsequent to the incubation. To 
avoid adulteration of results by phenol red in the medium, ACSF is used instead. For brain slice 
culture, 1 ml ACSF per incubation gets collected in a small vial. To obtain a positive control, 2 brain 
slices get placed in 3 ml ACSF in one well of the 6 well plate. In contrast to the incubated brain slices, 
they don´t get carbogenated and Triton X 100 is added to the culture medium in a final concentration 
of 0,1 %. After incubation, the brain slices in the positive control get destructed by frequent pipetting 
up and down. ACSF serves as a negative control. 
After collecting the samples, they are shortly centrifuged at 4 °C. To perform the assay, 100 µl 
supernatant per sample is placed in a 96 well plate. 100 µl working solution are added, and the plate 
has then to be incubated at room temperature in avoidance of light for 30 minutes. Afterwards, the 
absorbance is measured at a wavelength of 490 nm. 
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3.6 Glutamate assay 
3.6.1 Theory 
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Figure 12: Glutamic acid 
Glutamic acid is the most abundant excitatory neurotransmitter in the 
mammalian brain. 
 
Glutamic acid (see Figure 12) is a key element in cellular metabolism. As one of the two acidic 
proteinogenic amino acids, it is the most abundant swift excitatory neurotransmitter in the 
mammalian nervous system. It is also believed to be involved in learning and memory and has 
appeared to be involved in several diseases like cerebral ischemia, head and spinal cord injury, and 
prolonged seizure activity (Bittigau and Ikonomidou, 1997). The carboxylate anions and salts of 
glutamic acid are known as glutamates. 
3.6.2 Procedure 
To measure glutamate concentrations in the supernatant of the brain slice culture, we used a 
Glutamate Assay Kit, which resembles a sensitive and simple fluorometric method. The enclosed 
glutamate Enzyme Mix recognizes glutamate as a specific substrate leading to proportional color 
development. Therefore the amount of glutamate in the tissue culture supernatant can easily be 
quantified by colorimetric measurement in a plate reader (spectrophotometry at a wavelength of 
450 nm), measuring optic density. 
Thus, for each well of a 96 well plate, 100 µl reaction mix have to be prepared, containing 90 µl assay 
buffer, 8 µl glutamate developer and 2 µl glutamate enzyme mix. 100 µl of this reaction mix is added 
to each well containing the glutamate standard and the test samples. After mixing, the reaction gets 
incubated for 30 minutes at 37 °C in the dark. Then, optic density is measured at 450 nm in a 
microplate reader. To correct the background, the value derived from the 0 nmol glutamate control 
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has to be substracted from all the sample readings. Then, glutamate concentrations can be 
calculated with the help of the standard curve.  
3.7 Confocal imaging of brain slices 
Developed by Marvin Minsky in the 1950s, scanning confocal imaging nowadays serves as a general 
tool for live cell imaging applications. It can also be used to image fixed cells and tissue, labeled with 
one or several fluorescent probes. The fact, that confocal imaging can be used for optical sectioning, 
enables researchers to also address diverse biochemical questions (e.g. gene expression and 
cytoskeletal dynamics). 
 
 
Figure 13: Principle of confocal imaging 
 (Emptage, 2001) 
 
The term confocal microscopy derives from the fact that both the illumination and the detection unit 
are at the same conjugate focal plane (see Figure 13). Thereby, signals are only collected from the 
plane of focus. Additionally, a pinhole in front of the detector eliminates out-of-focus light. The most 
common form of confocal microscopes is the laser scanning confocal microscope (LSCM) (Watson, 
1997). In contrast to a common wide-field microscope, a confocal microscope can reveal the three-
dimensional structure of a specimen, by imaging a series of optical sections at different depths of the 
sample (Smith, 2008). 
With the help of antibodies, coupled to fluorescent dyes, it is possible to image different properties 
of cells concurrently. Fluorescent dyes are agents that emit light of a particular wavelength, after 
they got excited by light.  
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3.7.1 DiI staining 
DiI (1,1`-dioctadecyl-3,3,3`,3`-tetramethylindocarbocyanine perchlorate) belongs to the family of 
carbocyanine dyes. DiI is weakly fluorescent in water but reaches a high fluorescence when it is 
incorporated into membranes. 
The major mechanism of the staining process is lateral diffusion. The dye molecules diffuse along the 
cell membrane and become incorporated with their alkyl chains embedded in the lipid bilayer, 
resulting in a staining of the entire cell. DiI is maximally excited in the green and fluoresces bright 
red-orange, when viewed through a rhodamine filter. One big advantage is, that the dye is intensely 
fluorescent and that the fluorescence fades much more slowly than rhodamine fluorescence, e.g., 
making it a suitable approach for the staining and observation of neurons in brain slices (Honig and 
Hume, 1989). DiI and its analogs usually exhibit very low cell toxicity, making them also suitable for 
the staining of living cells. However, moderate inhibition of electron transport chain activity has been 
reported for some analogs of DiI (Anderson and Trgovcich-Zacok, 1995). 
3.7.1.1 Procedure 
To stain a small portion of neurons in the cortex and hippocampus of brain slices, the slices remain in 
the cell nets. The PBS gets removed, so that the slices still are slightly wet and don’t desiccate. Under 
a stereomicroscope, single crystals of DiI get applied with caution to the very surface of the brain 
slices. The tissue then is placed in a dark environment for 4 hours to ensure the dye had enough time 
to diffuse along the neuronal membranes. Afterwards, the slices get washed in PBS for 20 minutes 
and then mounted in mowiol. The slides are kept at 4 °C in the dark until observation.  
3.7.2 Immunohistochemistry 
For immunohistochemical staining, the brain slices get fixed in 4 % PFA overnight at 4 °C. Then, they 
get washed in PBS at room temperature on a shaker at 100 rpm for 10 minutes. To avoid waste of 
antibody, the brain slices are then transferred into a 24 well culture plate – each slice in one well. 
After washing, the brain tissue gets incubated with 1 % Triton-X 100 in PBS (1 ml per slice) at 100 rpm 
on a shaker at room temperature for 6 hours. To obtain a good membrane permeabilization, the 
slices remain in the Triton solution in the fridge at 4 °C overnight. On the next day, the brain slices 
get incubated with 4 % bovine serum albumine (BSA) in PBS (2 hours, RT, 200 rpm) to avoid 
unspecific binding of antibody. After aspiration of the BSA and a short washing step with PBS, the 
slices get incubated (300 µl per slice) with the primary antibody (mouse-anti-MAP2), diluted 1:200 in 
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PBS on a shaker at RT, 200 rpm overnight. On the next day, the tissue is washed five times with PBS, 
in each case for half an hour. The secondary antibody (Cy3-conjugated Goat-anti-mouse IgG) is 
diluted 1:200 in PBS (300 µl per brain slice), and the tissue is incubated at room temperature on a 
shaker (100 rpm) for 2 hours. After 5 washing steps of 30 minutes each, the brain slices get mounted 
in mowiol.       
3.8 Calcium imaging 
3.8.1 Theory 
As many cellular functions are tightly regulated by calcium, and PLY is supposed to lead to an influx of 
calcium into cells, the measurement of intracellular calcium concentrations is of high importance. To 
measure intracellular calcium levels ([Ca2+]i), the fluorescent dye fura-2 is widely used. Fura-2 is very 
sensitive and specific, and it can be loaded into intact living cells without disruption of cellular 
functions (Hayashi and Miyata, 1994). 
One big advantage of fura-2 is that upon calcium binding, the peak excitation wavelength shifts to 
shorter wavelengths. So the measurement of two excitation wavelengths can be used to measure 
[Ca2+]i  independently of dye concentration and cell thickness. Another advantage is the considerably 
improved selectivity for Ca2+ over other divalent cations (Grynkiewicz et al., 1985). 
The acetoxymethyl (AM) derivates of fura-2 (fura-2 AM) are very useful compounds for the study of 
living cells. The modification of carboxylic acids with AM ester groups results in uncharged molecules 
that can permeate cell membranes easily. Once inside the cell, the lipophilic blocking groups are 
cleaved by nonspecific esterases, rendering a charged form that leaks out of cells far more slowly 
than the uncharged molecules (Roe et al., 1990).  
3.8.2 Procedure 
For calcium measurements, we use primary astrocyte culture. The cells get seeded onto PLO-coated 
square cover slips. To avoid waste of cells and reagents, we use silicone inserts. After approximately 
5 days, the cells are 90 % confluent and ready for measurements. To get rid of the phenol red in the 
cell culture medium (to avoid disturbances in fluorescence), the cells are rinsed with PBS once. 
Fura-2 AM is dissolved in Dimethyl sulfoxide (DMSO) to obtain a stock solution of 1 mM. 
To load the cells with the fura-2 dye, we use modified artificial cerebrospinal fluid (mACSF). Per 1 ml 
of mACSF, 5 µl fura-2 stock solution are needed to to obtain a 5 µM solution of fura-2 AM in mACSF. 
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For the loading process, 200 µl of the fura-2 solution are applied to the cells, which then remain in 
the CO2 incubator for 30 minutes. After that time period, the cells are rinsed with mACSF once, and 
then placed in the incubator for another 30 minutes. Then, they are ready for measurement. To 
measure changes in intracellular calcium levels, the coverslip is observed with the help of an IonOptix 
microscope.   
3.9 Statistics and analysis 
Statistical analysis was carried out with Microsoft Excel 2007 and GraphPad Prism, version 4.2 for 
Windows (Graph Pad Software, Inc.). 
Analysis of pictures was carried out with ImageJ software, version 1.46a for windows (National 
Institute of Health, Bethesda, MD, U.S.). 
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4  
4.1 Laboratory equipment  
Table 2: General laboratory equipment 
Equipment Manufacturer 
Autoclaves Systec (V 150), HMC (HV-110) 
Balance Kern 572 
Carbogen gas Linde 
Centrifuge (table) Hettich Mikro 120   
Centrifuge for bacteria Eppendorf Centifuge 5417R 
Centrifuge, cooled 15/50 ml tubes Hettich 
Chambered coverslips Nunc 
Cooling module BioRad 
Drying chamber Memmert UNE 300 
flexiPerm culture inserts Sarstedt 
Freezer Heraeus (Hera freeze, -80 °C) 
Ice machine Scotsman (AF 200) 
Incubators Heraeus (Hera Cell 240), Memmert 
Instruments for cell preparation  WPI, Hartenstein, Roth 
Labware (cell culture plastics etc.) Sarstedt, Roth, StarLab, Eppendorf, Millipore, 
BD Falcon 
Laminar flow cabinet BDK Luft- und Reinraumtechnik GmbH 
Maxi Sorp plates Nunc, BD Falcon 
Microscope for cell culture Leica DMIL 
Needles Braun 
Orbital shaker NeoLab Shaker DOS-10L 
pH meter Hanna Instruments 
Photometer Perkin Elmer Instruments 
Pipettes (2,5-1000 µl) Eppendorf, Gilson 
Pipettus accu-jet pro 
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Plastic cuvettes Roth 
Plate Reader BioTek (EL 800) 
Power supply units BioRad (Power Pac 3000), Consort (EV 231) 
Precision balance Sartorius 
Razor blades Valet Auto Stop Blades 
Refrigerators Liebherr 
Stirrer Heidolph 
Surgical disposable scalpels Braun 
Surgical Instruments  Roth, Hartenstein 
Syringes Braun 
Thermomixer Eppendorf 
Variable speed pump BioRad 
Vibratome World Precision Instruments (WPI) NVSLM  
Vortex IKA 
Water bath Memmert 
 
Table 3: Chemicals 
Chemicals  
Aqua purificata Roth 
Acetone Roth 
Ampicillin Roth 
N-Methyl-D-aspartic acid (NMDA) Sigma  
Boric acid Sigma 
Bovine serum albumine (BSA) Roth 
D-AP5  BIOMOL International L.P. 
DABCO Roth 
'DiI'; DiIC18(3) *crystalline*  Invitrogen 
Dimethylsulfoxide (DMSO) Roth 
Ethanol, ≥70%, p.a. Roth 
Ethanol, ≥99,8%, p.a. Roth 
D-(+)-Glucose, ≥99,5% Roth 
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L-Glutamic acid monosodium salt hydrate Sigma 
Glycerol Roth 
HEPES, PUFFERAN ≥99,5% Roth 
Potassium chloride Roth 
Magnesium chloride Roth 
Sodium chloride Roth 
Magnesium sulfate Roth 
Mowiol 4-88 Roth 
Paraformaldehyde Roth 
TRIS, PUFFERAN ≥99,9% Roth 
Triton X 100 Roth 
Trypan blue Roth 
Topical tissue adhesive World precision instruments 
LB-Agar (Lennox) Roth 
LB-Medium (Luria/Miller) Roth 
DNA Ladder 1kb Promega 
DNA Ladder 100bp Promega 
DNA Polymerase I Large (Klenow) Fragment Mini 
Kit 
Promega 
 
 
Table 4: Primary antibodies 
Primary Antibodies   
Anti-MAP2 Sigma/Santa Cruz 
Anti-Synapsin I Synaptic Systems 
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Table 5: Secondary antibodies 
Secondary Antibodies  
CyTM3-conjugated AffiniPure F(ab´)2 fragment goat 
anti-mouse IgG 
Jackson Immuno Research Laboratories Inc.  
CyTM3-conjugated AffiniPure F(ab´)2 fragment goat 
anti-rabbit IgG 
Jackson Immuno Research Laboratories Inc.  
Fluorescein (FITC)-conjugated AffiniPure F(ab´)2 
fragment goat anti-mouse IgG 
Jackson Immuno Research Laboratories Inc.  
Fluorescein (FITC)-conjugated AffiniPure F(ab´)2 
fragment goat anti-mouse IgG 
Jackson Immuno Research Laboratories Inc.  
 
Table 6: Software used for experiments and data evaluation 
Software Application 
IonWizard 6.1, Cairn research Calcium imaging 
GraphPad prism Data analysis, statistics 
LAS-AF Imaging analysis (confocal microscope) 
ImageJ Imaging analysis 
 
Table 7: Commercial kits used for experiments 
Commercial kits 
Quiagen Quiaprep Spin Miniprep Kit Quiagen 
Quiagen MinElute Gel extraction Kit Quiagen 
Quiagen MinElute Reaction Cleanup Kit Quiagen 
Glutamate Assay Kit BioVision 
LDH Cytotoxicity Detection Kit Clontech 
Limulus Amebocyte Lysate Kit Lonza 
MagnetofectionTM NeuroMag Oz Biosciences 
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4.2 Buffers and solutions 
 
Artificial cerebrospinal fluid (ACSF) 
 124 mM NaCl 
 2,5 mM KCl 
 2,0 mM MgSO4 
 1,25 mM KH2PO4 
 26 mM NaHCO3 
 10 mM glucose 
 4 mM sucrose 
 2,5 mM CaCl2 
 Adjust pH to 7.4 by aerating with 95 % O2, 5 % CO2 (carbogen) 
 
Mowiol 4-88 mounting medium: 
 2.4 g Mowiol 4-88 are mixed in 6 g Glycerol (in small vial) 
 Add 6 ml aqua destillata and leave stirring for approximately 3 hrs on RT 
 Add 12 ml Tris-Buffer, 0,2 M, pH 8.5 
 Heat up 10 minutes on 50 °C, agitate occasionally 
 Add 1,4-Diazobicyclo-(2,2,2)-octan (DABCO) up to 2,5 % to reduce fading 
 Centrifuge 15 min at 4 °C and 5000 g 
 Aliquot and store at -20 °C 
 
Paraformaldehyde fixative, 4 %  
 Heat 450 ml Aqua destillata in a glass beaker to 60 °C while stirring 
 Add 20 g paraformaldehyde powder 
 Cover and maintain at 60 °C 
 Add 5 drops of 2 N NaOH 
 Remove from heat and add 50 ml of 10X PBS 
 Adjust pH to 7.2 
 Aliquot and store at -20 °C 
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Poly-L-Ornithine (PLO) solution for coating of dishes 
 Solve 3,71 g  boric acid in 400 ml aqua bidest. 
 Add 100 mg PLO 
 Filtrate sterile 
 Aliquot and store at -20 °C 
 
Phosphate buffered saline (10x; PBS) 
 1,37 M NaCl 
 26,8 mM KCl 
 101,4 mM Na2HPO4 
 17,6 mM KH2PO4 
 Adjust pH to 7,3 
 
Modified artificial cerebrospinal fluid (mACSF) for calcium imaging 
 133 mM NaCl 
 3 mM KCl 
 1,5 mM CaCl2 
 1,2 mM NaH2PO4 
 1 mM MgCl2 
 10 mM D-glucose 
 10 mM HEPES 
 Filtrate sterile, store at 4 °C until use 
 
Live cell imaging buffer 
 135 mM NaCl 
 2 mM MgCl2 
 2 mM CaCl2 
 4 mM KCl 
 5 mM HEPES 
 Adjust pH to 7,4 
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Calcium-free live cell imaging buffer 
 135 mM NaCl 
 2 mM MgCl2 
 4 mM KCl 
 5 mM HEPES 
 Adjust pH to 7,4 
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5  
5.1 Live cell imaging of primary neurons 
To investigate the effects of pneumolysin on brain cells, we used a primary culture of hippocampal 
neurons, seeded onto PLO-coated chamberslides, transfected with GFP (as described in 3.4.2). Prior 
to each experiment, one healthy neuron (healthy neurons display a multiple branched dendritic tree, 
the GFP signal is strong, the cells don´t move upon shaking of the chamberslide) per chamber was 
chosen for observation (see Figure 14). Cells at the very edge of the chamberslide as well as cells with 
an unhealthy appearance were excluded from the experiments. 
 
 
 
Figure 14: Primary mouse neuron (DIV 14) 
For live cell imaging experiments only neurons with a healthy architecture were chosen. 
 
Suitable toxin concentrations for in vitro experiments were investigated in our lab by using primary 
astrocyte culture in a permeabilization assay using propidium iodide staining (Fortsch et al., 2011). 
Sub-lytic concentrations were considered between 0,05 and 0,2 µg/ml. Thus, in order to achieve 
proper sub-lytic effects without immediately destroying the cells, we utilized live cell imaging 
experiments with primary hippocampal neurons using a concentration of 0,1 µg/ml pneumolysin. 
5.1.1 Sub-lytic amounts of pneumolysin induce morphological changes in 
primary neurons 
The cells were investigated by using laser scanning confocal microscopy (LSCM), after transfection 
with green fluorescent protein (GFP). To investigate the cells in an environment close to physiological 
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conditions, the experiments were set up using a live cell imaging buffer, closely related to the 
cerebrospinal fluid (CSF), in a heating chamber on top of a heating plate, ensuring a constant 
temperature of 37 °C.  
The neurons were seeded at a density which ensures a proper growth and interconnection. Cells 
were used at an age of 14 to 21 days in vitro (DIV), when they already established cell-to-cell contacts 
and developed dendritic spines, resembling the synaptic compartments of the neurons. They were 
challenged with amounts of PLY, comparable to the PLY concentrations measured in the liquor of 
patients suffering from pneumococcal meningitis (0,1 µg/ml) (Spreer et al., 2003).  
All cells were observed for about 30 minutes. Observation of mock-treated control cells revealed no 
changes in cell shape, size or in the fluorescence of GFP. Even 3 hrs. after the imaging procedure,  
control cells revealed no damage, as shown in Figure 15. The cells still showed strong GFP 
fluorescence and a healthy architecture, excluding that phototoxicity damaged the cells significantly 
during the investigation. 
 
 
 
Figure 15: Primary mouse neuron 3 hours after observation 
Primary mouse neuron (DIV 19), 3 hrs. after investigation (30 minutes mock-treated live cell 
imaging, after 3 hrs. pictured again). The neuron still shows a healthy appearance and displays a 
lot of dendritic spines. Scale bar: 10 µm. 
 
Cells treated with sub-lytic amounts of pneumolysin showed various morphological changes during 
30 minutes of observation. The first signs of changes in cell morphology occurred during the first 
5 minutes after toxin application. The dendrites of the neurons developed focal swellings, referred to 
as varicosities (see Figure 16). However, these cells didn´t die, the swellings remained connected to 
each other, and the GFP signal remained strong. Also, they did not lose the contact to the bottom of 
the chambered glass slide.      
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Figure 16: Live cell imaging of primary neurons incubated with PLY 
Primary mouse neurons (DIV 14), transfected with a GFP construct. During 30 minutes of live cell 
imaging, the dendrites of the neurons showed focal swellings; dendritic spines were affected in number 
and appearance. The neurons stayed alive during the whole investigation. Scale bar: 5 µm. 
 
However, a few observed neurons died during investigation. Dying neurons can be identified easily. 
They lose contact to the bottom of the chamber slide and the GFP signal gets rapidly lost by protease 
degradation of the fluorescent protein and due to the breakdown of the neuronal cell membrane 
(see Figure 17).  
 
 
Figure 17: Dying neuron 
Dying neurons can be easily identified by a loss of the GFP signal (B) and the detachment from the 
bottom of the chamberslide. Scale bar: 10 µm. 
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From all the observed cells, 55 % remained unchanged, 15 % died, and about 30 % of all the neurons 
observed showed the formation of varicosities during the imaging process. Dying neurons were 
excluded from the statistics. 
Pneumolysin is known to produce extracellular calcium influx into the cells (Stringaris et al., 2002). To 
clarify the role of calcium influx in the changes we observed, we analyzed the role of pneumolysin in 
ca-free buffer conditions. The live cell imaging experiments carried out in calcium free buffer showed 
the same effects on dendrites and dendritic spines as experiments carried out in buffer with 
physiological calcium levels. 
As the formation of varicosities mostly refers to the injury of neurons induced by an over-stimulation 
of glutamate receptors, referred to as excitotoxicity (see 2.2), we investigated if an inhibitor of 
glutamate receptors is capable of reducing injuries. The neurons in hippocampus and cortex are in 
large part glutamatergic neurons (Megias et al., 2001). As these cells express NMDA receptors as 
main glutamate receptors, we used an inhibitor of the NMDA receptor (MK-801) to address our 
questions (see chapter 5.2.4.2). 
5.2 Establishing an acute brain slice culture 
In order to study the morphological changes arising during the incubation with pneumolysin in a 
more detailed way and in a more complex system, close to the in vivo situation, a suitable brain slice 
culture was developed. Aim of this application was to develop a method, with which it is possible to 
incubate acute brain slices with pneumolysin (and, for the future, with other toxins and compounds, 
too) while keeping them alive for several hours, and a reproducible staining method, allowing to 
stain and investigate single neurons in their natural environment. 
There are several brain slice culturing methods described in literature. First, we applied a method, 
where the brain slices were incubated on an orbital shaker using cell nets inserted in 6 well plates. 
The plates were kept in a cell culture incubator at 37 °C and 5 % CO2 during the whole toxin 
challenge. The cytotoxicity (measured LHD, released into the supernatant) of this approach was 
about 10 - 12 %. This led us to the implementation of a second approach, where we replaced the 
orbital shaker and accommodated the brain slices with oxygen by direct admission of carbogen into 
the culture medium through needles. 
By the addition of carbogen to the brain slice culture, we were able to scale down the relative LDH 
release (directly correlated with cell death) for more than 50 % (see Figure 18). 
 
Results 
 
56 
 
 
 
Figure 18: Cytotoxicity of two different brain slice culturing methods 
By improving the culturing method of brain slices with a constant gassing of carbogen, cytotoxicity could 
be reduced for more than 50 %. PLY treated brain slices were challenged with 0,2 µg/ml PLY for 5 hours. 
All values represent the mean ± SEM, n=11 for the carbogen method; n=4 for the shaker method; Mann-
Whitney-U-Test;  **p<0,01  
 
This method was finally used for all further brain slice experiments. The exact method is described in 
detail in Figure 19 as well as in 3.3.2. 
As a time frame for the incubation, we had chosen 5 hours of incubation. We investigated different 
time frames for incubation; from 2 to 24 hours. The first manifestations were observed 3 hours after 
toxin application. We used 5 hours of incubation, because during this time the toxin had the chance 
of distribution. When the slices were challenged with the toxin for more than 5 hours the effects 
weren´t aggravated. Additionally, when the time frame of incubation expands, several elements of 
uncertainty, like pH changes, contaminations, loss of medium, etc. have to be taken into 
consideration. 
As shown in Figure 18, the cytotoxicity of the pneumolysin treated, carbogenated brain slice 
culturing supernatant is not elevated in comparison to the mock-treated control. A slight elevation of 
LDH release is due to the slicing process, where it cannot be anticipated that cells get damaged at the 
very top of the slide, where the razorblade cuts the tissue.    
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Figure 19: Schematic of the brain slicing process 
The mouse brain gets sliced up in carbogenated ACSF (A). After removal of the cerebellum, the brain is 
glued on a specimen holder (B) and cut into 300 µm thick slices by a vibratome (C). The brain slices get 
transferred to a 6 well plate, where the slices are constantly gassed with carbogen gas during incubation 
at 37 °C (D+E). 
 
To ensure an observer-blinded study, we randomly numbered the glass slides the brain slices were 
mounted on. By constantly gassing the slices with carbogen (Figure 19 D), it was ensured, that the 
cells had enough oxygen for optimal survival. The medium contained glucose, which is essential for a 
proper functioning of brain cells. Antibiotics minimize the possibility of contamination during 
incubation. 
5.2.1 C57BL/6 mice (p7) brain slices 
First experiments were carried out with C57BL/6 mice at postnatal day 7 (p7). The neurons imaged 
were all alive prior to fixation with 2 % formalin. DiI is a compound which diffuses along the 
membrane, thereby staining the whole dendritic tree. This can only function properly, if the 
membrane is still intact which serves as proof of healthy neurons. 
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As depicted in Figure 20, after challenge with sub-lytic amounts of pneumolysin, the neurons also 
showed the same kind of focal swellings seen in the live cell imaging experiments. Although the brain 
slices represent a much more complex system, close to the in vivo situation.  
 
 
 
Figure 20: DiI stained neurons in the cortex of brain slices 
After 5 hours of incubation with sub-lytic amounts of pneumolysin (0,2 µg/ml), several neurons in the 
cortex of 300 µm mouse brain slices show focal swellings like they have been observed in the live cell 
imaging experiments. Scale bar: 20 µm  
 
 
 
By counting both varicosities and dendritic spines in the depicted dendrites, we could show an 
increase in the formation of focal swelling, as well as a slight reduction of dendritic spines (Figure 21).  
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Figure 21: Reduction of dendritic spines and number of varicosities in p7 mouse brain slices 
The slides were randomly numbered, blinding the experiments/conditions. Per each experiment, 4 brain 
slices per condition were incubated. After staining, 4 randomly chosen neurons per brain slice were 
depicted by confocal imaging, using z-stacks to picture the whole neuron. Per neuron, all the dendrites 
which could be clearly seen in the picture, were chosen for investigation of dendritic spines/varicosities.  
All values represent the mean ± SEM, n = 3 experiments (4 slices/condition/experiment); Mann-Whitney-
U-Test; *p<0,05. 
 
The varicosities ranged between 5-7 varicosities per 100 µm of the dendrite. The number of dendritic 
spines per 100 µm dendrite ranged between ~15 (mock) and ~10 (PLY). 
5.2.2 C57BL/6 mice (p14) brain slices 
Because of the fact, that at the age of 7 days, the mouse brain has not established that much spines 
and dendrite branching, we investigated the effects of PLY also in brain slices of p14 mice.  
5.2.2.1 Ctrl vs. PLY 
 
Figure 22: DiI stained neurons in the cortex of 300 µm mouse brain slices 
Control neurons in the cortex of brain slices of p14 C57BL/6 mice show an established complex network 
of dendrites. Also the dendritic spines, representing the postsynapse, have established properly. Scale 
bar: 10 µm 
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In brain slices of p14 mice, the control cells showed the typical morphology of healthy neurons in 
their natural environment (Figure 22), the dendrite morphology remained unchanged under control 
conditions (mock-treated brain slices; 5 hours incubation at 37 °C with the carbogen method, 
described in 3.3.2).   
 
 
Figure 23: Dendrites of neurons in brain slices show morphological changes upon PLY challenge 
After challenge with pneumolysin, the dendrites show clear signs of varicosity formation (arrows). Scale 
bar: 10 µm 
 
In this model, pneumolysin also caused a significant reduction of dendritic spines as well as an 
increase in varicosities (see Figure 23 and Figure 24). 
 
 
Figure 24: Reduction of dendritic spines and induction of varicosities in brain slices incubated with sub 
 lytic amounts of pneumolysin 
 
After 5 hrs. incubation with 0,2 µg/ml pneumolysin, brain slices of C57BL/6 mice, 14 days postnatal, show a 
significant reduction of dendritic spines and an increase in the formation of varicosities. All values represent 
the mean ± SEM, n = 4 experiments (4 slices/condition/experiment); Mann-Whitney-U-Test; ***p<0,001. 
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As shown in Figure 24, the dendrites in the older brain slices show more dendritic spines in general 
(about 35 per 100 µm dendrite). Upon PLY challenge, the spines get reduced for about 30 %. The 
varicosities range between 3 and 5 per 100 µm dendrite. The number of varicosities in the older 
brain slices is slightly increased in comparison to the number of varicosities in the p7 brain slices. 
The reduction of dendritic spines as well as the formation of varicosities over time is statistically 
highly relevant.  
To visualize dendrite morphology, we also used an immunofluorescence method with a monoclonal 
antibody against the dendrite-specific microtubule-associated protein MAP2. As shown in  
Figure 25, mock-treated brain slices exhibit regular, healthy neurite architecture. 
 
 
 
 
Figure 25: MAP2 immunostaining of neurons in the cortex of C57BL/6 mice 
MAP2 immunostaining of cortical neurons in a brain slice of p14 C57BL/6 mice. 5h mock-treated. The 
architecture of the dendrites is intact, they show a regular morphology. Scale bar: 30 µm 
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Upon PLY challenge, the development of varicosities can be visualized with MAP2 
immunohistochemistry, too (see Figure 26). Some of the depicted dendrites show irregular beadings. 
 
 
 
Figure 26: MAP2 immunostaining brain slices after PLY challenge 
After challenge with 0,2 µg/ml PLY for 5 hours, the cytoskeletal architecture of cortical mouse neurons is 
altered. Scale bar: 30 µm 
 
5.2.3 Cell culture conditions modulating the toxicity of pneumolysin 
As brain cell homeostasis is altered in the course of bacterial meningitis, we also investigated the 
toxicity of pneumolysin under disease-relevant conditions.  
If the brain slices are incubated on a shaker in the incubator, without a constant source of oxygen, 
pneumolysin leads to a higher cell death rate compared to the mock-treated brain slices (see Figure 
27). This deprivation of oxygen mimics dramatic conditions during pneumococcal meningitis, where 
some brain areas are affected by ischemia (Gerber and Nau, 2010).     
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Figure 27: Cell death induced by PLY (brain slice shaker method) 
All values represent the mean ± SEM; n = 4; Mann-Whitney-U-Test; *p<0,05 
 
The reduction of extracellular calcium levels is often correlated with an aggravated course of 
different systemic bacterial diseases (Ben-Abraham et al., 2002; Cooper and Morganelli, 1998). The 
incubation of mouse brain slices with PLY in two different extracellular calcium concentrations 
revealed a higher LDH release in a low-calcium extracellular milieu (see Figure 28).    
 
 
Figure 28: LDH release brain slices with differing calcium concentrations 
Brain slices incubated for 4 hours with or without 0.2 µg/ml PLY in the presence of 1 and 2 mM extracellular 
calcium. All values represent the mean ± SEM; n = 6 experiments (5 slices/condition/experiment) ; Mann-
Whitney-U-Test; *p<0,05 
5.2.4 Brain slices of mice with pneumococcal meningitis 
Brain slices of mice suffering from pneumococcal meningitis were kindly provided by Prof. Roland 
Nau and Prof. Wolfgang Brück from the Department of Neuropathology, University of Göttingen. The 
slices stem from C57BL/6 mice, ca. 2 months old, infected with S. pneumoniae. Two different 
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pathogen strains were used for infection. One strain was capable of producing pneumolysin, the 
other strain was a PLY-deficient one. For control, we were provided with brain slices from healthy 
mice at the same stage of development. By immunohistochemistry for both MAP2 (a dendritic 
protein) and synapsin (a presynaptic marker), we were able to measure the relative synaptic density 
in the cortex of these brain slices, comparing the fluorescence intensities for synapsin, normalized to 
the MAP2 signal in the same region in order to compensate sectioning differences. The analysis was 
limited to the layers I-III of the parietal cortex, positioned in adjacent vicinity to the CSF space, 
populated by the pneumococci. 
 
 
Figure 29: Relative synaptic density in the cortex of C57BL/6 mice suffering from 
pneumococcal meningitis 
 
Brain slices from mice infected with PLY+ or PLY- strains of Streptococcus pneumoniae. Immunohistochemistry 
for MAP2 and Synapsin. All values represent the mean ± SEM; Mann-Whitney-U-Test; *p<0,05 
 
As shown in Figure 29, there is a significant decrease in the synaptic density in the cortices of mice 
suffering from pneumococcal meningitis with PLY production in comparison to the mock-treated 
control mice as well as in comparison to the mice infected with a PLY-deficient mutant of the 
pathogen.  
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5.2.4.1 Delta6 mutant 
Challenge of brain slices with different concentrations of the delta6 mutant (unable to form pores) 
showed no effects in the number and appearance of dendritic spines, as well as in the formation of 
varicosities (data not shown). 
5.2.4.2 MK-801 – role in primary neuronal culture 
To investigate the effects of an inhibitor of NMDA receptors on the morphological cell shape changes 
observed after PLY treatment, we used MK-801 as a potent, non-competitive inhibitor of the NMDA 
receptor (Wong et al., 1986). The inhibitor was used in live cell imaging experiments and got added in 
a final concentration of 10 µM immediately after the first signs of varicosity formation. The whole 
imaging process took 30 minutes. 
 
 
 
 
Figure 30: Live cell imaging of primary mouse neurons (DIV 14) incubated with PLY and MK-801 
Primary hippocampal neurons, transfected with a GFP construct. Scale bar: 10 µm 
 
 
As shown in Figure 30, the addition of MK-801 led to a reversion of the morphological changes; 
almost to the original state. The same experiment was accomplished with neurons at DIV 21, as 
shown in Figure 31. Even at this stage of development, the inhibitor was capable of reverting the 
formation of varicosities. 
As depicted in Figure 30 and Figure 31, the addition of MK-801, applied to the cells after they showed 
the first signs of alteration, was capable to reduce the focal swellings induced by the toxin.  
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Figure 31: Live cell imaging of primary neurons (DIV 21) incubated with PLY and MK-801 
In live cell imaging experiments with primary hippocampal mouse neurons, the first signs of 
morphological alterations occurred 3 – 5 minutes after pneumolysin challenge (B). By immediate 
application of the inhibitor, the formation of varicosities could be reversed (C). Scale bar: 10 µm 
 
5.2.4.3 MK-801 – role in brain slice culture 
As the addition of MK-801 was capable of reverting the formation of varicosities in primary neuronal 
culture, we investigated if the inhibitor effects the formation of varicosities also in a more complex 
system like brain slices. As shown in Figure 32, incubation with 10 µM MK-801 concurrently with 
pneumolysin significantly reduced the number of varicosities.  
 
 
Figure 32: Dendritic spines and varicosities per 100 µm dendrite in mouse brain slices (p14) 
Brain slices incubated for 5  hours with  0.2 µg/ml PLY and MK-801.  All values represent the mean ± SEM; 
n = 4 experiments (4  slices/condition/experiment);  Mann-Whitney-U-Test; **p<0,01; ***p<0,001 
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As previously, PLY led to a decrease in the number of dendritic spines. 6 hours incubation with 10 µM 
MK-801 led to a significant decrease in the number of dendritic spines per 100 µm dendrite. 
The MAP2 immunohistochemical staining of brain slices that were preincubated with 10 µM MK-801 
prior to pneumolysin incubation showed a normal architecture of the dendrites in the cortex (see 
Figure 33). 
 
 
 
Figure 33: MAP2 immunostaining 
Brain slices incubated with 10 µM MK-801 one hour prior to 5 hrs. PLY incubation. Preincubation with 10 µM 
MK-801 leads to a preserved structure of dendrites. Scale bar: 30 µm. 
 
5.2.4.4 AP5 brain slice experiments 
We also investigated, if another inhibitor of NMDA receptors (AP5) is capable to reduce the focal 
swellings, induced by pneumolysin. Thereby it should be investigated, if the observed effects are due 
to a possible interference of MK-801 directly with the PLY pores, or if the effects are glutamate 
receptor specific. AP5, in contrast to MK-801, is a competitive inhibitor of NMDA receptors. It blocks 
the receptor by binding at the same binding site as glutamate.  
As shown in Figure 34, AP5 also leads to a significant reduction in the number of varicosities, caused 
by pneumolysin.  
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Figure 34: AP5 (10 µM) effects of the number of spines and varicosities  
All values represent the mean ± SEM. n = 3 experiments (4 slices/condition/experiment); Mann-Whitney-U-
Test; *p<0,05; **p<0,01; ***p<0,001 
 
As several publications mention that the AP5 inhibitor is more effective in concentrations of about 
50 µM, we incubated the brain slices with this higher concentration of AP5 and revealed the same 
results; a significant reduction of varicosities caused by pneumolysin (see Figure 35). 
 
 
 
Figure 35: Number of varicosities (50 µM AP5) 
All values represent the mean ± SEM. n = 1 experiment (4 slices/condition/experiment);  Mann-Whitney-U-
Test; ***p<0,001 
Results 
 
69 
5.3 Glutamate measurement 
To investigate if the observed effects on neuronal dendrites refer to a discharge of glutamate, we 
measured glutamate levels in the supernatant of the brain slice culture (for the exact method, 
see 3.6.2). With this method, no changes in the glutamate levels of brain slice culture could be 
observed (see Figure 36). 
 
 
Figure 36: Glutamate levels in the supernatant of brain slice culture 
An enzymatic glutamate assay did not observe any changes in glutamate levels in the supernatant of brain 
slice culture. All values represent the mean ± SEM. n = 3 experiments (4 slices/condition/experiment). 
 
Next, we investigated, if the reuptake of glutamate into brain tissue is affected after challenge with 
PLY. Therefore, brain slices were treated with 0,4 µg/ml pneumolysin for 4 hours. Afterwards, the 
slices got challenged with 100 µM glutamate for one additional hour. Subsequently, supernatant was 
taken to perform a glutamate assay. 
Figure 37 shows, that the uptake of glutamate into brain tissue was not altered after four hours of 
PLY incubation. 
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Figure 37: Reuptake of glutamate into brain slices 
The glutamate assay did not observe changes in the capacity to take up glutamate from the supernatant back 
into brain tissue. All values represent the mean ± SEM. n = 3 experiments (4 slices/condition/experiment). 
 
To investigate glutamate levels in brain slice culture over time, slices were challenged with 0,2 µg/ml 
pneumolysin for a time period of 5 hours. Every 30 minutes, 50 µl of supernatant were taken for the 
enzymatic glutamate assay.  
 
 
Figure 38: Glutamate levels in brain slice culture over time 
Over a time period of 5 hours, the glutamate concentrations in the supernatant of the brain slice culture rises 
slightly in control and PLY-treated experiments. In the culture, treated with high potassium levels, glutamate is 
elevated to a higher extent. 
 
As shown in Figure 38, the glutamate levels were elevated, when the slices were treated with high 
potassium levels. That is so far no surprise, as high levels of potassium lead to a prolonged 
depolarization of neurons (Jing et al., 1991). 
Results 
 
71 
The supernatant of the mock-treated tissue as well as the supernatant of the PLY-treated brain slices 
shows nearly no elevation of glutamate levels. All the slices from this experiment were stained with 
the help of a MAP2 antibody. 
 
 
 
Figure 39: MAP2 immunostaining of brain slices 
MAP2 immunostaining of neurons in the cortex of C57BL/6 mice (p14) after challenge with 50 mM potassium 
for 5 hours. Scale bar: 30 µm 
 
 
As depicted in Figure 39, brain slices which were challenged with a high concentration of potassium,   
known to lead to excessive depolarization of neurons, showed neurons with a high amount of 
varicosities in the dendrites. Nearly none of the observed neurons showed an intact architecture. 
5.4 Calcium imaging 
It is known, that pneumolysin leads to a calcium influx in vitro (Stringaris et al., 2002). To investigate, 
if this calcium influx may be blocked by the application of MK-801 (and thus indicate a provisional 
direct interaction of MK-801 with the PLY pores), we used primary astrocytic culture, loaded with 
fura-2. To measure elevated intracellular calcium, we used the IonOptix setup. With the help of this 
setup, it is possible to calculate the elevated intracellular calcium by measuring the increasing 
fluorescence of fura-2 AM (see 3.8.2). An example of such a calcium chart is shown in Figure 40. 
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Figure 40: Example of a calcium chart 
After addition of pneumolysin, the intracellular calcium concentration rises. Addition of ionomycin at the end 
of each experiment serves as positive control. 
 
The addition of Ionomycin (10 µM) at the end of each experiment served as a positive control, 
presumably equalizing the level of calcium inside and outside the cells. 
PLY led, as expected, to an increase in intracellular calcium levels after round about one minute. 
MK-801, which has been applied concurrently with pneumolysin, delayed the beginning of the rise of 
intracellular calcium for ca. 2 minutes (see Figure 41), without affecting the calcium level in the 
cytosol. 
 
 
Figure 41: Evaluation of the calcium experiments 
A: Time span till the beginning of the intracellular calcium rise 
B: Time span till the maximum calcium increase is reached 
All values represent the mean ± SEM; n = 6; Mann-Whitney-U-Test ; *p<0,05; **p<0,01 
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Additionally, MK-801 was able to delay the point of time, when the peak of calcium increase was 
reached for about 2 minutes (Figure 41 B). 
 
 
 
Figure 42:  Rise of intracellular calcium 
No change in the percental rise of intracellular calcium was observed. All values represent the mean ± SEM; 
n = 6. 
 
As shown in Figure 42, intracellular calcium levels were elevated for about 30 % after PLY challenge. 
The application of MK-801 was not capable of reducing the rise in intracellular calcium levels.  
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6  
Bacterial meningitis induced by the pathogen Streptococcus pneumoniae is still a devastating disease 
with high mortality rates, especially among little children and elderly people in developing countries. 
One major virulence factor of S. pneumoniae is the CDC pneumolysin. It has been shown that strains 
of S. pneumoniae which are not capable of producing pneumolysin, exhibit a reduced virulence (Hirst 
et al., 2008). The contribution of pneumolysin to a severe outcome of pneumococcal meningitis has 
recently been shown by Wall et al., who found out that PLY persists in the CSF of meningitis patients, 
even when the number of bacteria is lowered due to antibiotic therapy. The amount of PLY during 
suffering was higher in the CSF of non-survivors compared to the CSF levels of patients who survived 
the disease (Wall et al., 2012). 
There are several publications dealing with the effects of pneumolysin. However, most of these 
experiments were carried out with concentrations above the toxin levels found in the CSF of patients 
suffering from pneumococcal meningitis, as lytic pore formation occurs with higher concentrations of 
the toxin, milder effects and apoptosis in lower concentrations (Braun et al., 2002). Thus, we 
investigated toxin effects with concentrations ranging from 0,1 to 0,2 µg/ml, corresponding to the 
toxin levels found in the CSF of meningitis patients (Spreer et al., 2003). 
 
Brain damage in pneumococcal meningitis leads to long-term neurologic sequelae in 30 % of the 
survivors, manifested especially in hearing loss along with learning and memory deficits (Schmidt et 
al., 2006; Wellmer et al., 2000). Another manifestation of neurological impairment is the occurrence 
of seizures during childhood meningitis (Chao et al., 2008). Grimwood et al. found out that even 12 
years after recovery from bacterial meningitis, many of the intellectual and cognitive impairments 
still persisted (Grimwood et al., 2000). The risk of long-term neurological sequelae is highest in low-
income countries, where the burden of meningitis is highest (Edmond et al., 2010). 
 
As several mechanisms seem to be involved in the processes leading to such a severe outcome of this 
form of meningitis, the aim of this thesis was to clarify the role of pneumolysin in the establishment 
of neurological deficits during and after recovery from pneumococcal meningitis. 
 
During the work on this thesis, the effect of pneumolysin onto primary neurons was investigated. 
Therefore, a primary neuronal culture as well as a newly established acute brain slice model was 
used. Cells as well as slices were treated with sub-lytic amounts of pneumolysin, proven to be sub-
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lytic with the help of different methods in our lab (Fortsch et al., 2011). The effects were investigated 
by using two different staining methods and laser scanning confocal microscopy. Further insight was 
provided with the help of calcium imaging using primary mouse astrocytes. Modulations of the toxin 
induced effects were carried out with two different antagonists of the NMDA receptor.   
 
Because pneumococcal meningitis represents the greatest burden in children aged 0-5 (see Figure 2), 
we used mice at the age of 7 to 14 days for brain slice culture, when the brain architecture of mice is 
still developing and thus comparable to the brain architecture of infants. Additionally, brain slices of 
younger mice show a better survival during culturing than those of adult mice (Lipton et al., 1995). 
 
The very first findings we got by using primary neuronal culture, transfected with a GFP construct 
and investigated via confocal time-lapse imaging. We observed the induction of focal swellings along 
the dendrites of primary hippocampal neurons as well as the collapse of dendritic spines, starting 
approximately 3 minutes after sub-lytic pneumolysin challenge.  
The formation of regular dendritic beadings is well described in literature. In 1982, Purpura et al. 
examined the brain biopsies of 5 young children, suffering from severe neurobehavioral retardation 
of unknown etiology. In this brain tissue, over 90 % of neurons were affected by varicosity formation 
and loss of dendritic spines (Purpura et al., 1982). 
As 30 % survivors of pneumococcal meningitis suffer from neurological deficits like seizures or 
memory and learning disabilities, it appears obvious that our findings might be related to these 
deficits. Purpura et al. already proposed that the alterations in the dendritic structure of neuronal 
cells may represent a primary target in the pathobiological process underlying neurobehavioral 
failure (Purpura et al., 1982). 
Later studies more and more related the formation of varicosities to excitotoxic events, meaning the 
excessive or prolonged activation of glutamate receptors (Olney, 1990). These dendrite beadings 
occur after NMDA challenge (Ikegaya et al., 2001; McDonald and Johnston, 1993; Olney, 1969) as 
well as after application of kainic acid (Al-Noori and Swann, 2000; Oliva et al., 2002), which is 
commonly used in the field of epilepsy research to evoke seizures. These facts lead to the hypothesis 
that the dendritic beadings, occurring after challenge with sub-lytic concentrations of pneumolysin, 
are caused by a non-physiological activation of glutamate receptors. 
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Concurrently with the regular beading of the dendrites, we observed a decrease in the number of 
dendritic spines in the areas of the beadings. The formation of varicosities is often accompanied with 
the loss of dendritic spines:  
In 2001, Hasbani et al. used cultured cortical neurons, either expressing yellow fluorescent protein or 
stained with DiI, for sublethal excitotoxic exposure (NMDA, kainate or oxygen-glucose deprivation). 
With the help of time-lapse microscopy, they tracked the fates of dendritic spines. The neurons 
underwent dendritic beading and the loss of approximately 50 % of dendritic spines. Consistent with 
our findings, they observed most spine loss in regions of local dendrite swelling. They also 
investigated the recovery of dendritic spines along the dendritic shafts (Hasbani et al., 2001). If the 
dendritic spines reemerge after washout of pneumolysin (or inactivation with cholesterol) should be 
investigated with the help of further experiments.   
 
To shed a bit more light on the disappearance of the dendritic spines, we were provided with brain 
slices from adult mice, suffering from pneumococcal meningitis. With synapsin I as a marker for the 
presynapse, we could show that the synaptic density is decreased in the cortex of mice suffering 
from pneumococcal meningitis with a Streptococcus pneumoniae strain, capable of producing 
pneumolysin. The fact, that the synaptic density was not decreased to that extend in mice which are 
infected with a strain of Streptococcus pneumoniae lacking the ability to produce pneumolysin, leads 
to the conclusion, that pneumolysin is directly involved in the seen effects. 
In 1993, Rosahl et al. showed that a synapsin I knockout in mice leads to learning and memory 
deficits (Rosahl et al., 1993). Pneumolysin leads to a reduction in synapsin I, which might be an 
additional explanation for the cognitive impairment after recovery from pneumococcal meningitis. 
 
However, additional experiments should be performed, testing if the morphological changes 
observed really correlate with functional impairment. During cerebral ischemia, neurons undergo 
rapid alterations in their dendritic structure consisting of focal swelling and spine loss. Hasbani et al. 
could show that presynaptic and postsynaptic elements remained in physical proximity throughout 
spine loss and recovery (Hasbani et al., 2001). These results suggest that an elimination of dendritic 
spines is not necessarily associated with the loss of synaptic contacts.  
 
None of the effects mentioned above were observed after incubation with the delta6 mutant of 
pneumolysin (a completely non-pore-forming mutant), neither in primary culture, nor in acute brain 
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slice culture. This leads to the hypothesis that membrane-binding and the formation of pores are 
required for the induction of excitotoxic events through pneumolysin. 
 
Several publications mention that neurotoxicity of pneumolysin is dependent on calcium influx 
through the pore (Stringaris et al., 2002), and excitotoxic events are also related to a calcium influx 
through activated glutamate receptors (Hoskison et al., 2007). When we investigated time lapse 
imaging with primary neurons in calcium free buffer the formation of varicosities wasn’t abolished. 
This leads to the hypothesis that neurons not only become damaged by pneumolysin through 
calcium influx into the cells. The formation of focal swellings seems to be independent of calcium 
influx. 
Several studies mentioned already that varicosity formation is independent of calcium influx into the 
cell: Swann et al. stated in 2000 that the cellular mechanisms underlying varicosity formation and 
spine loss appear to be different. They postulated that the loss of dendritic spines is produced by 
calcium-mediated alterations of the spine cytoskeleton, while dendritic beading is independent of 
calcium influx, but dependent on intracellular sodium and chloride movement (Swann et al., 2000), 
which goes along with our findings, that varicosity formation wasn´t abolished in calcium-free buffer. 
Additionally, it has been postulated that dendritic beading occurs much more rapidly than calcium 
dependent excitotoxic cell death (Hasbani et al., 1998; Swann et al., 2000). 
 
To investigate the effects we saw with the help of primary neuronal culture in a more complex 
system, we developed a reproducible acute brain slice culturing method.  
There are several brain slice culturing methods described in literature. One prominent method has 
been described by Stoppini et al. in 1991. For experiments, they placed the slices on top of a 
membrane at the interface between air and culture medium (Stoppini et al., 1991). This model is 
suitable to study physiological mechanisms occurring during the first days in culture. A big 
disadvantage is that upon treatment with different compounds (PLY in our case), only one side of the 
brain slide gets in contact with the toxin. Another disadvantage is that the top of the slide will be 
covered with astrocytes over time. That does not refer to the original in vivo state and makes analysis 
of toxin effects more complicated. 
Another method described in literature is the roller model. Due to this culturing method, the brain 
slices are kept in glass bottles and, for incubation, placed on top of a horizontal roller. Thereby, the 
brain slices are free-floating in medium during toxin challenge, ensuring the toxin to contact all sides 
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of the brain slice (Victorov et al., 2001). The major disadvantage of this method is the lack of fresh 
oxygen.    
To combine the best properties of both methods, we did some modifications. By placing the whole 
brain slices in the culture medium, it is ensured, that the toxin has contact to all sides of the slice. By 
constant gassing with carbogen, it is ensured, that the slices are provided with enough oxygen. 
Glucose supplement to the culture medium ensures proper functioning of brain cells over time. 
 
Neuronal morphology in the tissue context was visualized using the fluorescent membrane tracer DiI 
or by immunohistochemistry with an antibody to the dendrite-specific microtubule-associated 
protein MAP2.  
DiI is widely used as a retrograde or antegrade neuronal tracer. The dye is suitable for the staining of 
neurons in dissociated cultures (Honig and Hume, 1986, 1989) as well as for tracing neurons in brain 
slices by focal application of single crystals (Hosokawa et al., 1992; Seabold et al., 2010) or by using a 
suspension of DiI in PBS (Park et al., 1996). Especially for the staining of dendritic spines, which are 
near the resolution limit for optical microscopy, DiI tracers represent a simple but effective staining 
method. In our case, we applied single crystals directly to several cortex areas, to ensure a proper 
staining of single neurons in these brain regions. DiI does not spread from labeled to unlabeled 
neurons, ensuring single stained neurons in the complex network of brain tissue (Honig and Hume, 
1986).  
As it has been shown that brain slices, fixed with lower concentrations of paraformaldehyde solution 
than typically used (4 %), show a better distribution of the DiI compound, we used a 2 % PFA solution 
for fixation (Kim et al., 2007). It is important to use preheated PFA for the fixation process, as it has 
been shown that chilled solutions can cause a reduction of dendritic spines in brain slices (Kirov et al., 
2004). The medium should contain a certain amount of glucose, as oxygen-glucose deprivation is 
known to induce varicosities in the dendrites of cultured cortical neurons (Park et al., 1996). 
 
By using the shaker method for the incubation of brain tissue, the leakage of LDH into the 
supernatant is enhanced in comparison to the carbogenated brain slice culturing model. This might 
be due to the fact that the brain tissue is not sufficiently provided with oxygen. It should be taken 
into consideration, to use this method as a model for ischemic tissue insults; to examine the 
pathophysiology of brain diseases with the help of a model of an ischemic tissue context. 
In our case, this brain slice culturing method does not make much sense, because it has been shown 
that ischemia causes varicosity formation itself (Hori and Carpenter, 1994). The aim of this work was 
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to identify the effects directly mediated by pneumolysin. Therefore, we had to abolish all other 
mediators of changes. 
 
By reducing the extracellular calcium levels during PLY challenge in brain slice culture from 2 mM to 
1 mM, we observed a higher LDH release, corresponding to a higher cytotoxicity. This means that PLY 
concentrations, which were proven to be sub-lytic, can become lytic in consequence of decreased 
extracellular calcium levels (Wippel et al., 2011). The reduction of extracellular calcium levels is often 
correlated with an aggravated course of different systemic bacterial diseases. Hypocalcemia is 
especially observed in patients suffering from streptococcus group A bacteremia and sepsis (Ben-
Abraham et al., 2002; Cooper and Morganelli, 1998). However, it should be taken into consideration, 
that lower calcium levels in the serum are not necessarily correlated with decreased calcium levels in 
the CSF of the patients. Interesting about these findings is, that streptolysin O (a protein toxin 
produced by group A streptococci) belongs to the family of cholesterol-dependent cytolysins, too 
(Johnson et al., 1980). Another point to consider is that the experiments were performed with 
calcium levels which correspond to the calcium levels in the CSF of rodents (Jones and Keep, 1988). In 
humans, CFS calcium levels are round about 0,6 mM (Bereczki et al., 2000), which might be due to a 
higher lytic capacity of pneumolysin in human patients. 
 
As previously mentioned, we used a second method to visualize the dendrites in brain slices besides 
DiI: immunohistochemistry with an antibody against MAP2. MAP2 is a neuron-specific protein, 
selectively localized in the dendrites and somata of neurons. This protein is thought to be involved in 
the assembly of microtubules by crosslinking microtubules with other microtubules and intermediate 
filaments (Bernhardt and Matus, 1984). With the help of this staining method, we were also able to 
visualize the dendritic beadings, suggesting that the observed effect is not only dependent on 
osmotic changes or malformation of the plasma membrane, but also dependent on changes in the 
cytoskeleton of the depicted neurons. 
 
Swann et al. described in 2000 the same dendritic abnormalities in studies with human epilepsy 
tissue and comparable animal models of focal epilepsy. Like several studies before, they connected 
the excessive release of glutamate during seizures to the occurrence of these abnormalities (Swann 
et al., 2000). Focal swellings or varicosity formation in dendrites and loss of dendritic spines are the 
earliest indications of glutamate-induced excitotoxicity (Tseng and Firestein, 2011). In 2005, Takeuchi 
et al. mentioned that dendritic beading can be induced by activated microglia and occurs through 
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NMDA receptor signaling. They stated that blockage of NMDA receptors may be an effective 
therapeutic approach for neurodegenerative diseases (Takeuchi et al., 2005). 
Thus, we decided to investigate, if an inhibitor of the NMDA receptor is capable of anticipating the 
effects mediated by pneumolysin. With the help of MK-801 we could reverse the formation of 
varicosities in some of the experiments. This finding leads to the hypothesis, that pneumolysin-
mediated neurotoxicity directly involves the activation of NMDA receptors. 
However, blocking the NMDA receptors is a double-edged sword as it can lead to neuronal death, 
too. Normal activation patterns of the NMDA receptor have been shown to be neuroprotective 
against both apoptotic and excitotoxic events (Hardingham, 2009). Additionally, many clinical trials 
using NMDA receptor antagonists in the field of stroke, traumatic brain injury and dementia have 
failed due to poor tolerance and efficiency. These trials involved more than 9000 patients, but none 
of the agents used revealed therapeutically relevant. The only exception was magnesium, which 
showed benefits in the treatment of subarachnoid haemorrhage (Muir, 2006). 
Ikonomidou and Turski proposed, that NMDA receptor antagonists failed in stroke and traumatic 
brain injury trials in human beings because blocking the NMDARs, and thereby synaptic transmission, 
hinders neuronal survival (Ikonomidou and Turski, 2002). 
In our experiments, MK-801 significantly reduced the number of dendritic spines itself; an effect that 
is already known (Butler et al., 1999) and also exhibits MK-801 as an inappropriate compound for the 
implementation in clinical trials.  
 
AP5 serves as another inhibitor of the NMDA receptor. In contrast to MK-801, it competitively 
inhibits the glutamate binding site of the receptor (Morris et al., 1986). In our experiments, AP5 
showed the same effects concerning the suppression of varicosity formation. This is a hint that 
MK-801 abolished dendrite beading really by blocking the NMDAR and not via direct interaction with 
pneumolysin or the PLY pores. Unfortunately, AP5 is not really a good alternative to MK-801 as it has 
been shown that it inhibits learning and memory processes (Davis et al., 1992). This is consistent with 
our findings that AP5 reduced the number of dendritic spines itself. 
 
It is known that microtubule dynamics are involved in varicosity formation. Disintegrated 
microtubules and a reduction in the immunoreactivity against MAP2 have been found in swollen 
dendrites (Tomimoto and Yanagihara, 1992). In 2006, Hoskison and Shuttleworth observed an 
aggregation of MAP2 into dendritic beadings after a brief exposure to excitotoxic agents, referring to 
a depolymerization of microtubules (Hoskison and Shuttleworth, 2006). In 2003, Buddle et al. found 
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out that the NMDA receptor resides in a complex with MAP2 and that the activation of the NMDA 
receptor plays a prominent role in the breakdown of MAP2 (Buddle et al., 2003). This goes along with 
our findings, where pneumolysin leads to an altered MAP2 signal in immunohistochemistry that can 
be blocked with an inhibitor of the NMDA receptor. 
Tseng and Firestein proposed a mechanism, where the post-synaptic density-95 protein (PSD-95) is 
involved in the modulations of the microtubule cytoskeleton during exposure to sublethal excitotoxic 
events (Tseng and Firestein, 2011). PSD-95 is a postsynaptic neuronal scaffolding protein, located in 
dendritic spines. It associates with N-methyl-D-aspartate receptors and links them to intracellular 
signaling molecules (Watanabe et al., 2003). Additionally, Morales and Fifkova postulated that MAP2 
may organize actin filaments in dendritic spines and endow the actin network of the spines with 
dynamic properties that are necessary for synaptic plasticity (Morales and Fifkova, 1989). Thus, it 
seems possible that the formation of varicosities is indirectly related to the loss of dendritic spines. 
 
As several studies mention that the morphological changes after excitotoxic insults disappear within 
2 hours after the excitotoxic agents have been removed (Faddis et al., 1997; Hasbani et al., 1998; 
Park et al., 1996), it should be taken into consideration if it is more reasonable to work on the 
reduction of the compounds which lead to excitotoxicity (pneumolysin, in our case) than to block the 
receptors directly. 
 
Despite the finding that varicosity formation is independent of calcium influx, we performed some 
experiments, measuring the elevation of intracellular calcium levels with the help of primary mouse 
astrocytes. These cells are easier to handle, less vulnerable and since the cells have to be rinsed 
several times during the fura-2 loading process, a good alternative. Due to the fact that NMDARs are 
also present in mouse astrocytes (Verkhratsky and Kirchhoff, 2007) and even in human astrocytes 
(Lee et al., 2010), they represent a good model for the investigation, if MK-801 is capable of altering 
calcium influx patterns, as it has been postulated that glutamate excitotoxicity is strongly dependent 
on calcium influx (Manev et al., 1989). The elevation of intracellular calcium levels for about 30 % 
could not be dropped down after addition of MK-801, which is no surprise, as pneumolysin arouses 
calcium influx itself. The delay of the time span till the rise of intracellular calcium begins and the 
time span till the calcium peak is reached, might be due to the fact that MK-801 blocks calcium influx 
through the NMDA receptor and thus, calcium mainly rushes into the cell through the pneumolysin 
pore itself. 
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Another interesting point concerning the calcium influx into astrocytes is that several studies found 
out, that astrocytes release glutamate themselves in response to elevated intracellular calcium levels 
(Bonansco et al., 2011; Perea and Araque, 2007). The release of glutamate by astrocytes after 
pneumolysin challenge might be another reason for overexcited neurons and the development of 
excitotoxic insults.   
 
Glutamatergic transmission is central for diverse brain functions, being particularly important for 
learning, memory, and cognition. In normal brain homeostasis, glutamate, released by neurons 
during synaptic transmission, gets cleared up from the synaptic cleft via uptake by astrocytes. As it is 
known that astrocytes get damaged upon challenge with pneumolysin (Fortsch et al., 2011; Hupp et 
al., 2012) we investigated if the capacity of glutamate uptake into brain tissue is affected.  
Surprisingly, we could not observe any changes in glutamate levels; neither in the glutamate 
reuptake capacity of brain tissue nor in the discharge of glutamate from brain tissue into the 
supernatant. 
In 2007, Braun et al. linked the neurotoxicity of pneumolysin to the damage of mitochondria (Braun 
et al., 2007). It is known, that mitochondrial dysfunction increases the vulnerability of neurons 
towards dendritic beading during normal physiological activity (Greenwood et al., 2007). This might 
be an explanation why we could not observe any changes in the glutamate status of brain tissue. 
Maybe pneumolysin damages mitochondria and thus makes the neurons more vulnerable to 
physiological glutamate concentrations. However, Braun et al. used the toxin in concentrations of 0,2 
to 0,5 µg/ml for an incubation time of up to 6 hours, which are relatively tough conditions for 
primary neurons. It should be taken into consideration to investigate, if there is any damage of 
mitochondria induced by sub-lytic amounts of pneumolysin.   
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This is the first time, a study connected pneumolysin not only to cell damage, cell death and 
apoptosis in brain cells, but to excitotoxicity. 
 
Future research, based on the findings of this thesis, will focus on a further clarification of the 
glutamate effects induced by pneumolysin. First follow-up experiments with a highly sensitive 
glutamate probe will check if the enzymatic assay used in our experimental setup wasn´t just 
sensitive enough or if there is really no change in the glutamate status of brain tissue upon 
pneumolysin challenge.  
 
To ensure, that only pyramidal neurons are observed in the brain slices, a genetically modified mouse 
model will be introduced. These mice express GFP in a small amount of their cortical, pyramidal 
neurons. By studying the effects of pneumolysin with the help of brain slices from these mice, it is 
possible to diminish one error source: the staining process. Additionally, it ensures a random staining 
of neurons and is also time-saving. 
 
As the NMDAR antagonists MK-801 and AP5 exhibited severe side-effects (such as cognitive 
disruption) in clinical trials, other options for the prevention of excitotoxic insults should be taken 
into consideration. 
 
The introduced brain slice culturing method represents an easy, cheap and very good reproducible 
method. With this application, it is possible to maintain brain slices for several hours (in our 
experiments up to 24 hours) alive. For further experiments, it is possible to adopt these ex vivo 
models for the screening of therapeutic molecules as well as for the testing of different compounds 
with regard to their neurotoxic potentials. 
 
As the loss of dendritic spines is not necessarily associated with the loss of synaptic contacts (Hasbani 
et al., 2001), this question should be addressed in further experiments, searching for a possible 
connection between morphological and functional alterations. One possibility could be 
electrophysiological measurements in brain slices.   
All in all it should be taken into consideration to develop agents that directly inhibit pneumolysin, as 
this may represent an additional useful therapy for pneumococcal meningitis. 
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